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ABSTRACT 
 
Congenital diaphragmatic hernia (CDH) results from a defect in the diaphragm through which 
abdominal contents enter the thorax displacing the heart and the lungs. This causes lung 
hypoplasia and varying degrees of pulmonary hypertension resulting in high rates of morbidity 
and mortality. Though CDH has a prevalence rate of 2.61 per 10,000 live births it is an expensive 
birth defect with an estimated annual cost of nearly $250 million for all CDH survivors. Maternal 
exposure to air pollutants have not been studied as risk factors for CDH in humans. Ambient 
ozone has been found to be risk factors for certain birth defects including congenital heart 
defects, chromosomal anomalies, and limb reduction defects. Cadmium, however, has been 
found to be a risk factor for diaphragmatic hernia, cleft palate, renal defects, anopthalmia, 
microphthalmia, anal atresia, undescended testes, and dysplastic ears in animal studies only. The 
objectives of this study were to: 1) examine the prevalence, temporal trends, and correlates of 
CDH among live-born infants during 1998–2012; 2) investigate the association between 
sociodemographic and perinatal characteristics and neonatal and one-year survival among infants 
with CDH and its subtypes, isolated and complex; 3) examine the role of ambient ozone as a risk 
factor for CDH; and 4) determine the association between maternal exposure to ambient 
cadmium in air and CDH and assess if maternal smoking during pregnancy is an effect modifier 
of the cadmium-CDH association. To answer these questions we used a population-based, 
retrospective cohort study using data from the 1998–2012 Florida Birth Defects Registry. We 
classified CDH cases into isolated and complex. A case that was associated with other anomalies 
listed on the National Birth Defects Prevention Network list of major structural reportable 
 vii 
 
defects was classified as complex CDH. We used Poisson and joinpoint regression models to 
compute prevalence ratios and assess temporal trends, respectively. Kaplan-Meier survival 
curves and Cox proportional hazards regression were used to describe neonatal and one-year 
survival and estimate hazard ratios of neonatal and one-year mortality. We then used multilevel 
Poisson regression models to examine the association between maternal exposure to ambient 
ozone and CDH as well as cadmium and CDH. We conducted stratified analyses to test for effect 
measure modification by maternal smoking status. The study population to answer the first two 
questions consisted of 3,209,775 live-born infants (including 1,025 cases). To answer the third 
and fourth questions, the study population consisted of 3,039,685 and 2,591,395 live-born infants 
(including 981 and 840 cases), respectively. We found a 4% increase in the annual prevalence of 
CDH among complex cases, but no trend for isolated cases. We observed higher prevalence of 
CDH among infants born to mothers with high school or less maternal education and for multiple 
births. Female sex and maternal obesity were found to be associated with decreased risk for 
CDH. The most important predictor of neonatal and one-year mortality was gestational age<37 
weeks and birthweight <1,500g irrespective of the subtype of CDH. An unusual finding was the 
low risk for one-year mortality for multiple births compared to singletons among overall and 
isolated CDH. We did not find an association between maternal exposure to ambient ozone and 
CDH. The findings for maternal exposure to ambient ozone and different categories of CDH as 
well as etiologically relevant time windows for CDH were inconsistent and not significant. 
Among mothers who smoked during pregnancy, we found more than two times higher risk for 
CDH in the highest compared to the lowest quartile of ambient cadmium exposure among overall 
and isolated cases. Among overall and isolated cases, we observed more than 20% increased risk 
of CDH among mothers who smoked during pregnancy in the highest compared to lowest 
 viii 
 
quartile of ambient cadmium exposure (with the lower limit of confidence interval equal to one). 
Future research is needed to investigate the role of socioeconomic disparities, gene-environment 
interactions, interactions between dietary factors and ozone/cadmium, and other criteria and 
toxic air pollutants in the etiology of CDH. 
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CHAPTER ONE 
 
Introduction and theoretical framework 
Congenital diaphragmatic hernia (CDH) is a birth defect with a prevalence of 2.61 per 10,000 
live births in the United States.1 Despite its rarity it is an expensive birth defect with an annual 
cost of $158 million in the United States2 and the projected burden for all CDH patients exceeds 
$250 million/year.3 Infants with this defect have severely compromised respiratory and 
cardiovascular functions resulting in high mortality and morbidity. About 21% ̶ 31% of these 
infants die within 24 hours of birth.4,5 However, there exists a “hidden mortality” for this defect 
because pregnancies that end in stillbirths and abortions (elective or spontaneous) may be missed 
by surveillance registries resulting in underestimation of the mortality rate.6 Advanced neonatal 
care including extracorporeal membrane oxygenation (ECMO) before surgical repair and 
improvement in surgical procedures have increased survival rates over the years, but with high 
morbidity rates.7  
CDH is the herniation of the abdominal contents through a congenital defect in the 
diaphragm.8 It can be classified into isolated or complex/non-isolated. About 50%–60% of CDH 
are isolated, whereas the rest co-occur with other congenital anomalies, chromosomal 
abnormalities, or single-gene anomalies.9 The most common co-occurring anomaly is a 
congenital heart defect, which occurs in 20% of the CDH cases.10 Other co-occurring anomalies  
include orofacial and body wall defects.11 About 10% of all individuals with CDH have a 
chromosome abnormality and the most common are trisomy 18 and isochromosome 12p 
(Pallister-Killian syndrome).12  
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The primary mechanism proposed for the development of CDH is the disruption of the 
retinoic acid (RA) pathway during lung morphogenesis.13 The RA pathway hypothesis is 
demonstrated by decreased levels of retinol in human infants with CDH. Infants with retinol 
levels <0.61 µmol/L have over 14.11-fold odds of CDH (95% confidence interval [CI]: 1.95, 
102.00) compared to infants with retinol levels above this level.14 The disruption in the RA 
signaling pathway has been primarily suggested in cases associated with major congenital 
anomalies whereas in isolated cases only subtle disruptions are seen. 
Little is known about the etiology of CDH. Chromosomal and genetic syndromes such as 
Trisomy 18 and Pallister syndrome account for 10%–15% of the cases of CDH.15 The risk for a 
subsequent pregnancy to be affected has been estimated to be 2%.16 Sociodemographic 
characteristics that have been linked with CDH include maternal smoking and alcohol 
consumption during pregnancy,5,17 male sex, maternal Caucasian race, maternal age beyond over 
40 years,5 increased paternal age,18 prepregnancy obesity,19 and parity. Environmental factors 
and dietary factors have been proposed as possible risk factors for CDH. Deficiency of vitamin 
A, choline, cysteine, selenium, and magnesium20 and intake of the immunosuppressant 
mycophenolate mofetil21 and sulfonamide22 have been identified as risk factors for CDH in 
humans; non-steroidal anti-inflammatory drugs have been identified in animals.23 
Ozone 
Air pollution has been linked to numerous adverse health outcomes including birth 
defects. The criteria air pollutant, ozone, has been found to be a risk factor for congenital heart 
defects like aortic artery and valve defects, pulmonary artery and valve anomalies,24 oral clefts,25 
chromosomal anomalies,26 and limb reduction defects.27 In a single pollutant model, maternal 
exposure to ambient ozone in the highest quartile of exposure during the first three months of 
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pregnancy has been associated with 2.68 odds for aortic artery and valve defects compared to 
maternal exposure in the lowest quartile of ambient ozone exposure. In the same study, in a 
multipollutant model, maternal exposure to ambient ozone in the highest quartile of exposure 
during the first three months of pregnancy has been associated with 2.94 odds for pulmonary 
artery and valve defects compared to maternal exposure in the lowest quartile of ambient ozone 
exposure.24 However, a study conducted in seven Texas counties found odds ratios of 0.61 and 
0.64 for ventricular septal defects among mothers exposed to ambient ozone in quartiles 3 and 4, 
respectively, during 3–8 weeks of pregnancy compared to mothers exposed to ambient ozone in 
the lowest quartile.28 A 10-ppb unit change in maternal exposure to ambient ozone in the during 
the first and second months of pregnancy has been found to be associated with 17% and 22%, 
increased odds respectively, of cleft lip.25 In contrast, the above study in seven Texas counties 
did not find an association between maternal exposure to ambient ozone during weeks 3–8 of 
pregnancy and oral clefts.28 A 10-ppb increase in maternal exposure to ambient ozone during 1-4 
weeks of gestation has been found to be associated with 39% increased odds of limb reduction 
defects.27 In addition to the above teratogenic effects, increased levels of ambient ozone has been 
found to be associated with decreased sperm concentration and average sperm count.29 Maternal 
exposure to high ozone levels have also been found to be associated with adverse reproductive 
and fetal outcomes including low birth weight, and intra-uterine growth restriction.30  
Under the Clean Air Act, the U.S. Environmental Protection Agency (EPA) has set up 
ambient standards for the criteria air pollutants including ozone. There are two types of national 
ambient air quality standards: primary and secondary. The 2015 primary and secondary 
standards for ozone is 0.07ppm for 8 hours. In humans, ozone can persist for periods up to 18 
hours after the exposure.31  
 4 
 
Cadmium 
Cadmium compounds are one of the 30 urban air toxics that have been have identified by 
the US Environmental Protection Agency (EPA) as a subset of hazardous air pollutants that pose 
the greatest threat to public health in the majority of urban areas.32 It has also been classified as a 
possible carcinogen by the International Agency for Research on Cancer.33 The major 
anthropogenic sources of particulate cadmium (as elemental cadmium and cadmium oxide, 
sulfide, and chloride) are burning of fossil fuels like coal or oil, secondary smelters, fuel 
combustion, phosphate fertilizer manufacture, and municipal and sewage sludge incinerators.33 
Cigarette smoke and ingestion of contaminated food and water are other sources of cadmium.34 
Due to its long half-life of 15–20 years in the human body35 cadmium can accumulate and cause 
a variety of adverse outcomes. Animal studies have found that during pregnancy hepatic 
cadmium can be mobilized to the kidneys and placenta.36 Cadmium compounds can damage 
primary spermatocytes, decrease oocyte formation, and cause skeletal and neurological defects,34 
cleft palate,37 diaphragmatic hernia, renal defects, anopthalmia, microphthalmia, anal atresia, 
undescended testes, dysplastic ears,38 and low fetal weight;34 however, there is no evidence for 
its teratogenicity in humans. 
Study Rationale 
Experimental studies have found decreased serum retinol levels in rats exposed to 
ozone.39 This finding combined with evidence from a Netherlands’study depicting decreased 
retinol levels in infants with CDH14 suggests a possible role for ozone as a risk factor for CDH. 
The rationale for studying the association between maternal exposure to ambient cadmium in air 
and CDH is that cadmium can alter the levels of expression of the genes involved in RA 
metabolism mostly by inducing oxidative stress40 leading to the development of CDH. 
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Goals and objectives 
The long-term goal of the study was to assess the role of environmental exposures in the 
etiology of CDH. More specifically, the objectives of the study were: 
1. To examine the prevalence, temporal trends, and correlates CDH among live-born infants 
during 1998–2012 in the State of Florida.  
2. To investigate the association between sociodemographic and perinatal characteristics 
and early survival among infants with CDH and its subtypes, isolated and complex. 
3. To examine the role of ambient ozone as a risk factor for CDH in the State of Florida 
4. To investigate the degree to which maternal exposure to ambient cadmium concentration 
is associated with increased risk of CDH and CDH subtypes in offspring and to assess if 
maternal smoking during pregnancy is an effect modifier of this association 
Study Implications 
The contribution of this study is significant because adds to the largely unknown etiology 
of CDH in humans. Furthermore, despite a biologically plausible mechanism, there is limited 
evidence for environmental exposures as risk factors for CDH in humans. This approach is 
innovative because it focuses on novel environmental risk factors, ozone and cadmium, for CDH. 
It is expected that the results of this study will lead to a better understanding of the role of these 
pollutants in the development of CDH.  
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CHAPTER TWO 
MANUSCRIPT 1 
The Prevalence, Correlates, and Survival of Infants with Congenital Diaphragmatic Hernia 
in Florida 
ABSTRACT  
OBJECTIVE 
To identify the live-birth prevalence, trends, correlates, and neonatal and one-year survival rates 
of congenital diaphragmatic hernia and its subtypes, isolated and complex, in Florida. 
METHODS 
Using a population-based, retrospective cohort study design, we examined 1,025 cases of CDH 
from the 1998–2012 Florida Birth Defects Registry. We used Poisson and joinpoint regression 
models to compute prevalence ratios and temporal trends, respectively. Kaplan-Meier survival 
curves and Cox proportional hazards regression were used to describe neonatal and one-year 
survival and estimate hazard ratios representing the predictors of infant survival. 
RESULTS 
The birth prevalence of CDH was 3.19 per 10,000 live births (95% Confidence Interval [CI]: 
3.00-3.39). During 1998–2012 there was a 4.0% increase per year among complex cases only. 
Among all cases, maternal education less than high school (prevalence ratio: 1.25, 95% CI: 1.02-
1.53) and high school/associate degree/GED (prevalence ratio: 1.15, 95% CI: 1.01-1.32), and 
multiple birth (prevalence ratio: 1.38, 95% CI: 1.05-1.81) were associated with increased risk 
while female sex (prevalence ratio: 0.85, 95% CI: 0.76-0.95) and prepregnancy maternal obesity 
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(prevalence ratio: 0.78, 95% CI: 0.64-0.96) was protective of CDH. The 24-hour, neonatal, and 
one-year survival rates were 93.6%, 79.8%, and 71.2%, respectively. The highest hazard ratio of 
7.55 (95% CI: 4.52-12.61) was for neonatal mortality among isolated cases born <37 weeks at 
<1,500 grams. Among complex cases, multiple birth (hazard ratio: 0.41, 95% CI: 0.20-0.86) was 
associated with decreased one-year mortality.  
CONCLUSION 
Low maternal education, multiple birth, infant sex, and prepregnancy maternal obesity may be 
linked to CDH. The trends in prevalence, epidemiologic correlates, and predictors of early 
survival can differ between CDH subtypes, isolated and complex.  
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INTRODUCTION  
Congenital diaphragmatic hernia (CDH), a rare birth defect of the diaphragm, has an estimated 
prevalence of 2.61 per 10,000 live births in the United States1 and health care costs of over $250 
million per year.2 The 24-hour mortality is 21%–31%,4,5 whereas the one-year mortality can be 
as high as 46%.5 In recent years, prenatal diagnosis and advanced neonatal care have decreased 
mortality; however, survivors face complex morbidities that may require long-term medical 
support.7,41,42  
About 50%–60% of CDH cases are isolated,9 while the remainder co-occur with 
additional birth defects. Sociodemographic characteristics associated with this defect include 
maternal smoking during pregnancy,5 periconceptional alcohol consumption,17 advanced 
maternal age,5,43 Caucasian race,5 prepregnancy obesity,44 nulliparity,43  male sex,5,45 and 
increased paternal age.18 Fetuses with CDH are at risk for preterm birth and are small for their 
gestational age.45 Prior research have either used birth certificate data that has low sensitivity 
(33%) and positive predictive value (64%) for CDH compared to birth defects registry data,46 
examined a single risk factor,18 have few cases,17,44 or are not recent.43,45 Though there is 
extensive research on clinical and anatomic predictors of survival among these infants,4,12,45,47 
there is a paucity of current epidemiologic studies.  
Using a large population-based registry data we investigated the prevalence, temporal 
trends, and correlates of CDH among live-born infants during 1998–2012 in the State of Florida. 
We also investigated the association between sociodemographic and perinatal characteristics and 
early survival among infants with CDH and its subtypes, isolated and complex. 
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MATERIALS AND METHODS 
We conducted a population-based, retrospective cohort study using 1998–2012 data from the 
Florida Birth Defects Registry (FBDR). The FBDR is a passive, statewide, birth defects 
surveillance system that includes data on infants born alive to Florida resident mothers on or 
after January 1, 1998 and who have been diagnosed with one or more structural, genetic, or other 
specified birth outcomes, primarily identified using diagnostic codes present in clinical and 
administrative databases. The FBDR contains linked data from the Florida Vital Statistics birth 
and infant death records, the Agency for Health Care Administration hospital inpatient and 
ambulatory discharge databases, Regional Perinatal Intensive Care Centers’ data, Children's 
Medical Services (CMS) case management records, and CMS Early Steps data.48 The 
Institutional Review Boards at the University of South Florida and the Florida Department of 
Health have reviewed and approved the study. 
CDH cases were ascertained using the International Classification of Diseases, 9th 
Edition, Clinical Modification (ICD-9-CM) code 756.6, or 10th Edition (ICD-10) code Q79.0. 
Cases were then classified as isolated or complex. A complex CDH case was defined as having 
documentation of one or more concomitant defects listed on the National Birth Defects 
Prevention Network (NBDPN) list of major structural reportable defects (Table F).49 The 
sociodemographic and perinatal characteristics included in the study were obtained from the 
Florida Bureau of Vital Statistics and classified into risk factors and birth outcomes. Risk factors 
included maternal age, race/ethnicity, education, marital status, smoking during pregnancy, 
adequacy of prenatal care, parity, plurality, and infant sex. Birth outcomes included method of 
delivery, gestational age, and birth weight. Maternal age was categorized in years as <20, 20–24, 
25–29, 30–34, and ≥35; maternal race/ethnicity was categorized into white non-Hispanic, black 
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non-Hispanic, Hispanic, and other; and maternal education was categorized into <high school, 
high school equivalent, and >high school. Maternal marital status was dichotomized into married 
and not married, and method of delivery into vaginal and cesarean. Maternal smoking during 
pregnancy was dichotomized into ‘no’ and ‘yes’. Adequacy of prenatal care was dichotomized 
into ‘adequate’ and ‘not adequate’ based on the Kotelchuck index.50 Parity was classified into 
nulliparous and multiparous; plurality into singleton and multiple (twins, triplets, and higher-
order); and birth weight into <1,500g (very low birth weight or VLBW), 1,500–2,499g (LBW), 
and ≥2,500g (normal weight). Gestational age was assessed from the clinical estimate of 
gestation; implausible birth weight/gestational age combinations were excluded from the analytic 
sample.51 Data were then classified based on completed weeks as <33, 33–36, and ≥37. After 
cross-tabulation of frequencies of gestational age and weight at birth, a five-category combined 
variable was created: ≥37 weeks and ≥2,500g, ≥37 weeks and <2,500g and <37 weeks and 
<1,500g, <37 weeks and 1,500-2,499g, and <37 weeks and ≥2,500g. Prepregnancy body mass 
index (BMI) was categorized into underweight, normal weight, overweight, and obese. Dates of 
birth and death obtained from the Florida Bureau of Vital Statistics were used to calculate time-
to-death in days. 
Birth prevalence per 10,000 was computed as the number of CDH cases divided by the 
total number of live births during the entire study period, for each year, and then separately for 
isolated and complex subgroups. In addition to overall and annual rates, prevalence was 
calculated for each level of selected sociodemographic and perinatal characteristics. Using a 
Poisson distribution, 95% confidence interval (CI)s were computed around each prevalence 
estimate. Temporal trends in prevalence, specifically annual percent changes, were then 
estimated with joinpoint regression, which uses a Monte Carlo permutation test to assess whether 
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there are statistically significant changes in trends over time.52 Poisson regression models53 were 
used to calculate crude and adjusted prevalence ratios of CDH (overall and stratified by its 
subtypes, isolated, and complex) for each sociodemographic and perinatal characteristic. Two 
sets of multivariable models were run for overall, isolated, and complex cases, resulting in a total 
of six models. The first model included all risk factors; the second model consisted of birth 
outcomes and risk factors. We then used Kaplan-Meier curves to describe survival among cases 
(overall and stratified by its subtypes, isolated, and complex). Cox proportional hazard 
regression models were then used to calculate crude and adjusted hazard ratios that represent the 
association between sociodemographic and perinatal characteristics and neonatal and one-year 
survival among infants with CDH (overall and stratified by its subtypes, isolated, and complex). 
The proportional hazards assumption was assessed using log (-log) survival plots, Schoenfeld 
residuals, and covariate-by-time interaction terms. Missing data ranged from zero percent for 
plurality to 7.8% for prenatal care. Multiple imputation with ten imputed datasets was applied for 
all the six models. Prepregnancy BMI was available only for 2004–2012. Therefore, the above 
six models were rerun after the addition of prepregnancy BMI to each one them. All analyses 
were conducted using SAS 9.4 (SAS Institute Inc., Cary, NC, USA) except the joinpoint 
analyses for which purpose the Joinpoint Regression Program Version 4.5.0.0 (Statistical 
Methodology and Applications Branch, Surveillance Research Program, National Cancer 
Institute; 2017) was used. 
 
RESULTS 
Data from 1,025 live-born infants diagnosed with CDH resulted in a prevalence of 3.19 per 
10,000 live births (95%CI: 3.00-3.39) in Florida for 1998-2012. Of these, 782 (76.3%) were 
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isolated and 243 (23.7%) complex. Complex cases were associated with congenital heart defects 
(80%), chromosomal anomalies (15.4%), genitourinary defects (9.8%), central nervous system 
defects (4.5%), limb defects (2.8%) and other birth defects (21.5%). Analysis of 15 years of 
prevalence data for overall and isolated CDH found no significant trend; however, among 
complex cases the annual percent change during this period was 4.0% (95% CI: 1.2-6.9) (Figure 
2.1). 
 The distribution of most of the sociodemographic and perinatal characteristics including 
maternal race/ethnicity were similar between cases and noncases. However, cases had higher 
rates of cesarean delivery (49.0% versus 33.0%), male sex (56.3% versus 51.2%), and were less 
likely to be born ≥37 weeks and ≥2,500g (63.0% versus 87.0%) (Table 2.1). Among risk factors, 
the highest prevalence was among multiple birth (4.71 per 10,000 live births). For birth 
outcomes, infants born ≥37 weeks and ≥2,500g had the lowest prevalence at 2.31 per 10,000 live 
births. After adjusting for confounders, compared to mothers with more than high school 
education, mothers with less than high school and high school/associate degree/GED education 
had prevalence ratios of 1.25 (95%CI:1.02-1.53) and 1.15 (95%CI:1.01-1.32), respectively. 
Additionally, the prevalence ratio was 1.38 (95%CI: 1.05-1.81) for twins/higher order multiples 
compared to singletons and 0.85 (95%CI: 0.76-0.95) for female infants compared to male 
infants. For the combined effect of gestational age and birth weight, the highest prevalence ratio 
of 5.23 (95%CI: 4.13-6.62) was observed for the category, <37 weeks and <1,500g compared to 
≥37 weeks and ≥2,500g. For cesarean births, the prevalence ratio was 1.55 (95%CI: 1.39-1.74) 
compared to a vaginal birth (Table 2.1).  
When stratified by the type of defect, isolated and complex, we found the risk of isolated 
CDH to be 18% lower among female infants than for male infants. However, we did not find any 
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of the variables to be risk factors for CDH. For the combined effect of gestational age and birth 
weight, the lowest prevalence ratio among both isolated and complex cases was for the category, 
<37 weeks and ≥2,500g compared to ≥37 weeks and ≥2,500g (Table 2.2). As for overall cases, 
we observed a higher prevalence ratio for cesarean than for vaginal births among both isolated 
(prevalence ratio: 1.46, 95%CI: 1.29, 1.65) and complex (prevalence ratio: 1.42, 95%CI: 1.19, 
1.70) cases.  
The 24-hour, neonatal, and one-year survival rates were 93.6%, 79.8%, and 71.2%, 
respectively. Isolated cases had better neonatal and one-year survival rates (Figure 2.2). The 
highest risk for neonatal and one-year mortality was for infants with isolated CDH who were 
born <37 weeks and had a birth weight <1,500g. These infants had 7.55 and 5.67 higher risk for 
neonatal and one-year mortality, respectively. In addition, among overall and isolated cases, 
compared to singletons we found that multiple births had over 50% lower risk for one-year 
mortality (Table 2.3). 
For the prepregnancy BMI analyses based on data for March 2004–December 2012, the 
highest prevalence of 3.94 among categories of BMI was noted for infants born to obese 
mothers. In the adjusted model, we found that mothers who were obese before pregnancy were 
less 22% (Table C.1) and 23% (Table C.2) likely to have an infant with overall and isolated 
CDH, respectively, compared to mothers who had a normal BMI before pregnancy. We also 
found lower risk of neonatal mortality for overall, isolated, and complex cases among mothers 
who were underweight before pregnancy compared to who had a normal BMI before pregnancy 
with the lowest risk among complex cases (hazard ratio: 0.31, 95%CI: 0.14, 0.77). For one-year 
mortality, similar associations were observed for overall and isolated cases only (Table C.3).  
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DISCUSSION 
In this population-based study of 3209,775 Florida live-born infants we identified high school or 
less maternal education and multiple birth as risk factors and female sex as protective of CDH. 
We found gestational age and birth weight combined to be risk factors for increased neonatal and 
one-year mortality among both isolated and complex cases. Being a twin /higher order multiple 
was protective of one-year mortality among overall and isolated cases.  
The CDH prevalence in this study was 23% higher than the national estimate (3.19 vs 
2.61 per 10,000 live births).1 We detected a significant trend in prevalence only for complex 
CDH only. Additionally, 76.3% of the cases were isolated; a finding higher than what has been 
reported in the literature.45 One explanation for these results is the changing FBDR case 
ascertainment data sources,54,55 potentially resulting in the reduced ability to capture some birth 
defects including CDH  and others like Trisomy 21, and spina bifida.54,55 Another reason could 
be a different group of birth defects constituting the definition of a complex case. Our use of 
NBDPN defects includes major anomalies diagnosed within the first year of life, of public health 
importance, and with adequate diagnostic accuracy.49  
  The finding that maternal education high school or less is a risk factor for CDH concords 
with the Born in Bradford study that found low maternal education was a risk factor for birth 
defects in general.56 Higher risk for this defect among mothers with high school or less education 
may reflect disparities in access to health care involving decisions regarding prenatal diagnostic 
tests or pregnancy termination. We also found a 38% higher risk of CDH among multiple births 
compared to singletons consistent with a 1996-2000 Florida study that found a 46% increased 
risk of birth defects among multiple births compared to singletons.57 In contrast to a 1995–2007 
study based on data from the Swedish Medical Birth Registry that found 81% higher odds of 
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CDH among infants born to obese mothers we found obesity to be protective of CDH among 
overall and isolated cases. One possible explanation for this difference could be that the Swedish 
study included data on stillbirths after 28 weeks of gestation whereas our study had only live-
born infants.  
Infants with CDH are at risk not only for prematurity and/or LBW/VLBW, but these 
characteristics can predispose them to increased infant mortality.45  The severe nature of this 
defect along with prematurity and/or LBW/VLBW may lead to increased early mortality. A 
reason for the increased risk for prematurity is that infants with CDH are at higher risk for 
cesarean compared to vaginal births. Since we found survival rates to be lower in LBW/VLBW 
infants, irrespective of gestational age, it may suggest a greater role for birth weight rather than 
gestational age in the prognosis of infants with CDH. In our study, the 24-hour and one-year 
survival rates were 93.6% and 71.2%, respectively, that are within the range reported in previous 
studies.5,45,47 Consistent with what has been found in the literature our study also found better 
survival rates among isolated CDH cases.12 A surprising finding is that multiple births had more 
than 50% lower risk for one-year mortality specifically among isolated cases. Another finding 
was that infants born to underweight mothers had lower risk for neonatal and one-year mortality 
compared to infants born to mothers with normal BMI. However, this finding should be 
interpreted with caution due to the small sample size within this category. 
Strengths of this study include its large sample size and assessment of associations 
among CDH, overall and stratified by its subtypes, isolated and complex. Florida has 
considerable diversity in its population, both in terms of race/ethnicity and maternal nativity; 
therefore, the results of this study could be generalized to a diverse population. The FBDR relies 
on linkage of discharge data to identify birth defects; 35.9% of live-born infants who die within 
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24 hours are missed by data linkage compared to infants alive after one year.58 This could have 
underestimated early mortality. Our study focused on live-born infants with CDH; therefore, 
pregnancies that end in stillbirths and abortions (elective or spontaneous) are missed by the birth 
defects registry resulting in underestimated prevalence and mortality rates. The estimates for the 
categories ≥37 weeks and <2,500g, and <37 weeks and <1,500g and the underweight BMI 
category should be interpreted with caution due to the wide confidence intervals.  This study was 
limited by lack of information on prenatal diagnosis, procedures performed, and severity of the 
defect, which could have biased the survival estimates. Self-reported maternal smoking during 
pregnancy is likely to be underreported59 among cases and noncases alike, resulting in 
nondifferential misclassification of the outcome; this likely biased measures of association 
toward the null. 
This study suggests a role for maternal education and multiple birth in the etiology of 
CDH. Further research into environmental factors or measures of socioeconomic status besides 
maternal education may elucidate the role of disparities in the etiology of CDH. Additional 
research and surveillance of the differential correlates and survival outcomes among isolated and 
complex cases is also warranted.   
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Table 2.1 Prevalence Rates/Ratios of Congenital Diaphragmatic Hernia by Sociodemographic and Perinatal 
Characteristics in the State of Florida:1998-2012 
Characteristic CDH 
N (%) 
No CDH 
N (%) 
Prevalence Ratea 
(95% CI) 
Adjustedb 
Prevalence Ratio 
(95% CI) 
Risk Factors     
Maternal age (years)     
<20 110 (10.7) 2,502,279 (10.7) 3.20 (2.65-3.85) 0.94 (0.76-1.16) 
20–24 257 (25.1) 811,838 (25.3) 3.16 (2.80-3.58) 0.97 (0.83-1.14) 
25–29 270 (26.3) 863,903 (26.9) 3.12 (2.77-3.52) 1.00 
30–34 230 (22.4) 722,802 (22.5) 3.18 (2.80-3.62) 1.03 (0.88-1.21) 
35+ 158 (15.4) 466,898 (14.6) 3.38 (2.89-3.95) 1.09 (0.91-1.30) 
Maternal Race/Ethnicity     
White Non-Hispanic 502 (49.3) 1,522,144 (47.6) 3.30 (3.02-3.60) 1.00 
Black Non-Hispanic 186 (18.3) 597,667 (18.7) 3.11 (2.69-3.59) 0.92 (0.79-1.08) 
Hispanic 295 (29.0) 952,350 (29.8) 3.10 (2.76-3.47) 0.91 (0.80-1.05) 
Other 35 (3.4) 126,183 (4.0) 2.77 (1.99-3.86) 0.88 (0.64-1.18) 
Maternal Education     
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Table 2.1 (Continued)     
< High School 153 (15.1) 437031 (13.7) 3.50 (2.99-4.10) 1.25 (1.02-1.53) 
High School/Associate 
Degree/GED 
524 (51.6) 1589850 (49.7) 3.29 (3.02-3.59) 1.15 (1.01-1.32) 
> High School  338 (33.3) 1170698 (36.6) 2.89 (2.59-3.21) 1.00 
Marital Status     
Not Married 447 (46.6) 1,371,707 (42.8) 3.26 (2.97-3.57) 1.00 
Married 577 (56.4) 1,836,809 (57.2) 3.14 (2.89-3.41) 0.98 (0.86-1.12) 
Maternal Smoking during Pregnancy 
No 931 (91.0) 1,836,809 (91.5) 3.18 (2.98-3.39) 1.00 
Yes 92 (9.0) 271,551 (8.5) 3.39 (2.76-4.15) 0.97 (0.80-1.19) 
Parity     
Nulliparous 671 (65.9) 2,138,807 (66.9) 3.14 (2.95-3.35) 1.00 
Multiparous 348 (34.1) 1,058,892 (33.1) 3.29 (2.96-3.64) 1.05 (0.93-1.18) 
Receipt of Prenatal Care     
Not Adequate 238 (25.9) 749,752 (25.3) 3.17 (2.79-3.60) 1.00 
Adequate 679 (74.1) 2,209,807 (74.7) 3.07 (2.85-3.31) 1.00 (0.88-1.14) 
Plurality     
 19 
 
Table 2.1 (Continued)     
Singleton 978 (95.4) 3,109,982 (96.9) 3.14 (2.95-3.35) 1.00 
Multiple 47 (4.6) 99,712 (3.1) 4.71 (3.54-6.27) 1.38 (1.05-1.81) 
Infant Sex     
Male 576 (56.3) 1,642,922 (51.2) 3.50 (3.23-3.80) 1.00 
Female 448 (43.7) 1,566,804 (48.8) 2.86 (2.61-3.14) 0.85 (0.76-0.95) 
Birth Outcomes     
Method of Delivery     
Vaginal 520 (51.0) 2,126,549 (67.0) 2.44 (2.24-2.66) 1.00 
Cesarean  499 (49.0) 1,047,451 (33.0) 4.76 (4.36-5.20) 1.55 (1.39-1.74) 
Gestational age and Birthweight     
≥37 weeks & ≥2,500g 646 (63.0) 2,792,818 (87.0) 2.31 (2.14-2.50) 1.00 
≥37 weeks & <2,500g 82 (8.0) 78,298 (2.4) 10.46 (8.43-12.99) 3.85 (3.09-4.80) 
<37 weeks & <1,500g 78 (7.6) 49,598 (1.6) 15.70 (12.58-19.60) 5.23 (4.13-6.62) 
<37 weeks & 1,500-2,499g 137 (13.4) 142,908 (4.5) 9.58 (8.10-11.32) 3.56 (2.97-4.27) 
<37 weeks & ≥2,500g 82 (8.0) 146,046 (4.6) 5.61 (4.52- 6.97) 2.07 (1.68-2.56) 
CDH = Congenital diaphragmatic hernia, CI = confidence interval  
Column percentages displayed. 
Frequencies may not add to the total due to missing data; percentage may not add to 100% due to rounding.  
aCongenital diaphragmatic hernia cases per 10,000 live births 
bRisk factors adjusted for other risk factors; birth outcomes adjusted for all other variables in the table 
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Table 2.2 Prevalence Ratios of Congenital Diaphragmatic Hernia, Isolated and Complexa, by Selected Sociodemographic and 
Perinatal Characteristics in the State of Florida:1998-2012 
  
Isolated 
CDH 
Complex CDH 
 
 
Characteristic 
Total Cases 
 
Cases 
N (%) 
Adjustedb 
Prevalence 
Ratio (95% CI) 
Cases 
N (%) 
Adjustedb 
Prevalence 
Ratio (95% CI) 
Total 1,025 782 (76.3)  243 (23.7)  
Risk Factors      
Maternal age (years)      
<20 110 (10.7) 83 (10.6) 0.93 (0.74-1.18) 27 (11.1) 0.97 (0.70-1.36) 
20–24 257 (25.1) 198 (25.3) 0.98 (0.82-1.16) 59 (24.3) 0.97 (0.76-1.25) 
25–29  270 (26.3) 209 (26.7) 1.00 61 (25.1) 1.00 
30–34 230 (22.4) 175 (22.4) 1.01 (0.85-1.21) 55 (22.6) 1.06 (0.83-1.36) 
35+ 158 (15.4) 117 (15.0) 1.04 (0.86-1.27) 41 (16.9) 1.14 (0.87-1.50) 
Maternal Race/Ethnicity      
White Non-Hispanic 502 (49.3) 395 (50.8) 1.00 107 (44.6) 1.00 
Black Non-Hispanic 186 (18.3) 135 (17.4) 0.88 (0.73-1.05) 51 (21.2) 1.07 (0.84-1.37) 
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Table 2.2 (Continued)      
Hispanic 295 (29.0) 224 (28.8) 0.90 (0.78-1.05) 71 (29.6) 0.98 (0.79-1.21) 
Other 35 (3.4) 24 (3.1) 0.81 (0.57-1.14) 11 (4.6) 1.08 (0.70-1.68) 
Maternal Education      
< High School 153 (15.1) 115 (14.9) 1.18 (0.95-1.47) 38 (15.8) 1.25 (0.91-1.71) 
High School/Associate Degree/GED 524 (51.6) 392 (50.7) 1.09 (0.94-1.26) 132 (54.8) 1.20 (0.97-1.49) 
> High School  338 (33.3) 267 (34.5) 1.00 71 (29.5) 1.00 
Marital Status      
Not Married 447 (46.6) 342 (43.8) 1.00 105 (43.2) 1.00 
Married 577 (56.4) 439 (56.2) 0.96 (0.83-1.11) 138 (56.8) 1.05 (0.85-1.29) 
Maternal Smoking during Pregnancy 
No 931 (91.0) 708 (90.8) 1.00 223 (91.8) 1.00 
Yes 92 (9.0) 72 (9.2) 0.99 (0.79-1.23) 20 (8.2) 0.95 (0.68-1.31) 
Parity      
Nulliparous 671 (65.9) 503 (64.7) 1.00 168 (69.4) 1.00 
Multiparous 348 (34.1) 274 (35.3) 1.08 (0.95-1.23) 74 (30.6) 0.96 (0.79-1.15) 
Receipt of Prenatal Care 
Not Adequate 238 (25.9) 179 (25.4) 1.00 59 (27.8) 1.00 
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Table 2.2 (Continued)      
Adequate 679 (74.1) 526 (74.6) 1.01 (0.88-1.17) 153 (72.2) 0.98 (0.80-1.20) 
Plurality      
Singleton 978 (95.4) 746 (95.4) 1.00 232 (95.5) 1.00 
Multiple 47 (4.6) 36 (4.6) 1.36 (1.00-1.84) 11 (4.5) 1.19 (0.75-1.88) 
Infant Sex      
Male 576 (56.3) 451 (57.8) 1.00 125 (51.4) 1.00 
Female 448 (43.7) 330 (42.3) 0.82 (0.73-0.93) 118 (48.6) 0.99 (0.84-1.18) 
Birth Outcomes      
Method of Delivery      
Vaginal 520 (51.0) 410 (52.7) 1.00 110 (45.6) 1.00 
Cesarean  499 (49.0) 368 (47.3) 1.46 (1.29-1.65) 131 (54.4) 1.42 (1.19-1.70) 
Gestational age and Birthweight      
≥37 weeks & ≥2,500g 646 (63.0) 524 (67.0) 1.00 122 (50.2) 1.00 
≥37 weeks & <2,500g 82 (8.0) 45 (5.8) 2.60 (1.96-3.46) 37 (15.2) 4.50 (3.27-6.18) 
<37 weeks & <1,500g 78 (7.6) 56 (7.2) 4.40 (3.35-5.80) 22 (9.1) 3.88 (2.55-5.89) 
<37 weeks & 1,500-2,499g 137 (13.4) 97 (12.4) 2.99 (2.42-3.69) 40 (16.5) 3.05 (2.26-4.12) 
<37 weeks & ≥2,500g 82 (8.0) 60 (7.8) 1.83 (1.45-2.34) 22 (9.1) 1.88 (1.33-2.65) 
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CI = confidence interval  
Column percentages displayed. 
Frequencies may not add to the total due to missing data; percentages may not add to 100% due to rounding.  
aA case that had associated birth defects listed on the National Birth Defects Prevention Network was categorized as complex.49 
              bRisk factors adjusted for other risk factors only; birth outcomes adjusted for all other variables in the table 
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Table 2.3 Neonatal and One-Year Survival Among Live-born Congenital Diaphragmatic Hernia Cases by Selected Sociodemographic and 
Perinatal Characteristics in Florida:1998–2012 
 Neonatal Period First Year of Life 
 All Cases Isolated CDH Complexa CDH All Cases Isolated 
CDH 
Complexa CDH 
Characteristics Hazard Ratio (95% 
CI) 
Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI) 
Hazard 
Ratio† (95% 
CI) 
Hazard Ratio 
(95% CI) a 
Risk Factors 
Maternal age (years) 
<20 0.97 (0.55-1.72) 0.90 (0.45-1.80) 1.51 (0.55-4.13) 1.05 (0.67-1.64) 0.96 (0.54-1.70) 1.40 (0.67-2.94) 
20–24 1.27 (0.84-1.91) 1.09 (0.66-1.80) 1.87 (0.86-4.06) 1.19 (0.85-1.66) 1.15 (0.76-1.75) 1.41 (0.76-2.63) 
25–29  1.00 1.00 1.00 1.00 1.00 1.00 
30–34 1.25 (0.83-1.87) 1.22 (0.75-2.01) 1.37 (0.64-2.90) 1.13 (0.80-1.59) 1.16 (0.76-1.78) 1.10 (0.60-2.01) 
35+ 0.99 (0.63-1.57) 0.76 (0.41-1.42) 1.52 (0.71-3.22) 0.97 (0.66-1.42) 0.83 (0.50-1.38) 1.11 (0.60-2.05) 
Maternal Race/Ethnicity 
White Non-
Hispanic 
1.00 1.00 1.00 1.00 1.00 1.00 
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Table 2.3 (Continued) 
Black Non-
Hispanic 
1.06 (0.72-1.56) 0.96 (0.59-1.56) 1.15 (0.59-2.24) 1.12 (0.82-1.54) 1.03 (0.69-1.54) 1.21 (0.71-2.09) 
Hispanic 0.91 (0.64-1.29) 0.88 (0.57-1.36) 0.86 (0.46-1.61) 0.91 (0.68-1.22) 0.88 (0.61-1.26) 0.95 (0.56-1.59) 
Other 1.08 (0.52-2.25) 0.93 (0.34-2.60) 0.85 (0.27-2.70) 1.32 (0.74-2.36) 0.83 (0.34-2.07) 1.97 (0.84-4.63) 
Maternal Education      
> High School 1.00 1.00 1.00 1.00 1.00 1.00 
< High School 1.30 (0.80-2.11) 1.59 (0.88-2.88) 0.70 (0.28-1.74) 1.35 (0.91-2.02) 1.41 (0.86-2.31) 1.03 (0.50-2.14) 
High School/ 
Associate 
Degree/GED 
0.94 (0.67-1.32) 1.11 (0.72-1.70) 0.54 (0.29-1.01) 0.94 (0.71-1.24) 1.02 (0.71-1.46) 0.62 (0.37-1.04) 
Marital Status       
Not Married 1.00 1.00 1.00 1.00 1.00 1.00 
Married 1.08 (0.77-1.51) 0.93 (0.61-1.43) 1.13 (0.62-2.06) 0.94 (0.71-1.24) 0.86 (0.60-1.23) 0.93 (0.58-1.50) 
Maternal Smoking during Pregnancy 
No 1.00 1.00 1.00 1.00 1.00 1.00 
Yes 1.33 (0.83-2.12) 1.50 (0.86-2.61) 1.02 (0.39-2.70) 1.07 (0.71-1.61) 1.25 (0.77-2.03) 0.74 (0.33-1.67) 
Parity       
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Table 2.3 (Continued) 
Nulliparous 1.00 1.00 1.00 1.00 1.00 1.00 
Multiparous 1.05 (0.78-1.42) 1.01 (0.70-1.47) 1.13 (0.66-1.93) 0.97 (0.76-1.25) 1.00 (0.73-1.36) 0.96 (0.61-1.51) 
Receipt of Prenatal Care     
Not Adequate 1.00 1.00 1.00 1.00 1.00 1.00 
Adequate 1.02 (0.71-1.47) 1.41 (0.87-2.26) 0.69 (0.39-1.22) 1.13 (0.84-1.51) 1.26 (0.86-1.85) 1.00 (0.61-1.62) 
Plurality       
Singleton 1.00 1.00 1.00 1.00 1.00 1.00 
Multiple 0.51 (0.27-0.97) 0.46 (0.21-1.03) 0.57 (0.19-1.70) 0.45 (0.25-0.80) 0.41 (0.20-0.86) 0.57 (0.22-1.49) 
Infant Sex       
Male 1.00 1.00 1.00 1.00 1.00 1.00 
Female 1.03 (0.78-1.37) 1.03 (0.72-1.47) 0.93 (0.57-1.52) 1.00 (0.79-1.26)  1.01 (0.75-1.35) 0.93 (0.62-1.39) 
Birth Outcomes       
Delivery Route       
Vaginal 1.00 1.00 1.00 1.00 1.00 1.00 
Cesarean  1.15 (0.86-1.53) 1.20 (0.83-1.73) 0.89 (0.54-1.46) 1.16 (0.91-1.47) 1.19 (0.88-1.62) 0.93 (0.62-1.40) 
Gestational age and 
Birthweight 
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Table 2.3 (Continued) 
≥37 weeks & 
≥2,500g 
1.00 1.00 1.00 1.00 1.00 1.00 
≥37 weeks & 
<2,500g 
3.80 (2.45-5.89) 3.70 (2.02-6.79) 2.88 (1.43-5.80) 3.65 (2.54-5.25) 3.37 (2.02-5.62) 3.10 (1.75-5.48) 
<37 weeks & 
<1,500g 
7.00 (4.64-10.55) 7.55 (4.52-
12.61) 
4.66 (2.24-9.70) 5.37 (3.75-7.71) 5.67 (3.61-8.90) 3.93 (2.05-7.51) 
<37 weeks & 
1,500-2,499g 
3.22 (2.19-4.73) 3.81 (2.40-6.06) 2.01 (0.97-4.15) 2.97 (2.17-4.08) 3.29 (2.23-4.87) 2.09 (1.19-3.67) 
<37 weeks & 
≥2,500g 
1.89 (1.10-3.26) 1.87 (0.94-3.71) 1.65 (0.65-4.20) 1.86 (1.21-2.87) 2.09 (1.23-3.55) 1.13 (0.51-2.51) 
CDH = congenital diaphragmatic hernia, HR = Hazard Ratio, CI = confidence interval  
aA case that had associated birth defects listed on the National Birth Defects Prevention Network was categorized as complex.49 
Each variable adjusted for all other variables in the table. 
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Figure 2.1 Temporal trends in congenital diaphragmatic hernia in the State of Florida, 1998–2012, 
among (A) all cases, (B) isolated cases, and (C) complex cases 
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Figure 2.2 Crude neonatal and one-year survival among congenital diaphragmatic hernia infants in 
the State of Florida, 1998–2012, by its subtypes, isolated and complex 
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CHAPTER THREE 
MANUSCRIPT 2 
Maternal Exposure to Ambient Ozone as a Risk Factor for Congenital Diaphragmatic 
Hernia 
ABSTRACT 
BACKGROUND: Congenital diaphragmatic hernia (CDH) is a musculoskeletal birth defect 
with a prevalence of 2.61 per 10,000 live births in the United States. Ambient ozone has been 
associated with several birth defects; however, there is limited evidence for its role in the 
etiology of CDH. 
OBJECTIVES: We examined the role of maternal exposure to ambient ozone concentration as a 
risk factor for CDH (overall and stratified by isolated and complex) in the State of Florida.  
METHODS: We conducted a population-based, retrospective cohort study using data from the 
1998–2012 Florida Birth Defects Registry and Environmental Protection Agency’s Air Quality 
System. Ozone exposure was assessed by combining data to determine concentrations for 
maternal census tract at delivery using an inverse distance square weighting method. Analyses 
included chi-square tests and multilevel Poisson regression models to calculate the risk of CDH, 
overall and stratified by isolated and complex. 
RESULTS: The study population consisted of 3,039,685 live births including 981 cases of CDH. 
We did not detect any significant association between maternal exposure to ambient ozone and 
CDH. For complex CDH, we found prevalence ratios of 1.16 (95% CI: 0.80, 1.68), 1.24 (95% 
CI: 0.86, 1.78), and 1.12 (95% confidence interval [CI]: 0.60, 1.29) for maternal exposure to 
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quartile 2 of ozone exposure during 1– 2, 3–12, and 4–12 weeks of pregnancy, respectively, 
compared to the lowest quartile of exposure. 
CONCLUSIONS:  
Our results do not support a link between maternal exposure to ambient ozone and CDH. Studies 
with better exposure assessment and inclusion of spontaneous and planned abortions may be 
needed. Gene-environment interactions and the study of maternal vitamin A status as a mediator 
in the pathway between ambient ozone and CDH may provide further information on the 
potential role of ambient ozone in the etiology of CDH.  
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INTRODUCTION 
Congenital diaphragmatic hernia (CDH) is a musculoskeletal birth defect with a prevalence of 
2.61 per 10,000 live births in the United States.1 It is characterized by the herniation of 
abdominal contents into the thorax through an opening in the diaphragm that results in varying 
degrees of pulmonary hypoplasia and hypertension.60 
Little is known about the etiology of CDH; chromosomal and genetic syndromes account 
for 10%–15% of the cases.12 Dietary factors and some drugs have been found to increase the 
likelihood of CDH. Notably, the immunosuppressant, mycophenylate mofetil,21 sulfonamide,22 
and maternal deficiency of vitamin A,20,61 choline, cysteine, selenium, and magnesium20 have 
been reported as risk factors for CDH. Parental and infant characteristics that have been found to 
be associated with this defect include maternal smoking and alcohol consumption before 
and/during pregnancy,5,17 Caucasian race, age over 40 years,5 prepregnancy obesity,19 increased 
paternal age,18 and male sex.5  
The primary biologic mechanism proposed in the pathogenesis of CDH is disruption of 
the retinoic acid (RA) pathway during lung morphogenesis.13 This disruption is found primarily 
in cases associated with major congenital anomalies; in isolated cases the reported disruption is 
subtle. The RA pathway hypothesis has been demonstrated by decreased levels of retinol in 
human infants with CDH.14 A hospital-based, case-control study of 22 case and 34 control 
mother-infant dyads in Rotterdam, Netherlands, found that infants with retinol levels <0.61 
mol/L have over 14-fold increased odds of CDH compared to infants with retinol levels above 
this level.14  
Ozone is a criteria air pollutant that is the main component of photochemical smog.62 It is 
a secondary pollutant that is formed as a product of reactions between primary pollutants 
 33 
 
including oxides of nitrogen and volatile organic compounds (VOCs) in the presence of sunlight 
and heat. These primary pollutants are emitted by a variety of sources, including motor vehicles, 
electric power plants, chemical plants, refineries, and other industrial facilities. Morning rush-
hour traffic is a major source. In humans, ozone can persist for periods up to 18 hours after the 
exposure.31 The 2015 primary and secondary standard for public health and welfare protection 
for ozone is 0.07 parts per million by volume (ppmv) calculated as the annual fourth-highest 
daily maximum 8-hour concentration averaged over three years. 
Ozone has been associated with adverse reproductive and fetal outcomes including low 
birth weight, intra-uterine growth retardation,30 and birth defects. It has been reported to be 
associated with congenital heart defects such as aortic and pulmonary artery and valve 
defects,24,63 chromosomal anomalies,26 and limb reduction defects.27 
Experimental studies in rats have found decreased serum retinol levels in those exposed 
to ozone.39 This evidence combined with the above-mentioned study that found decreased retinol 
levels in infants with CDH suggests a possible role for ozone as a risk factor for CDH. The 
objective of this study was to identify the role of ambient ozone as a risk factor for CDH in the 
State of Florida.  
 
MATERIALS AND METHODS 
Study Population. Using data from the Florida Birth Defects Registry (FBDR) we conducted a 
population-based, retrospective cohort study of infants born alive between January 01, 1998 and 
December 31, 2012. The FBDR is a passive, statewide, population-based birth defects 
surveillance system established in 1999 that includes data on infants born to Florida resident 
mothers on or after January 01, 1998. It consists of data on infants who have been diagnosed 
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with ≥ 1 structural, genetic, or other specified birth outcomes, primarily International 
Classification of Diseases, 9th Edition, Clinical Modification (ICD-9-CM) diagnosis codes in the 
740–759.9 code range.48 Ozone concentration data for Florida and the neighboring states of 
Georgia and Alabama were obtained from the Environmental Protection Agency (EPA)’s Air 
Quality System (AQS).64. This study was reviewed and approved by the Institutional Review 
Boards at the University of South Florida and the Florida Department of Health. 
Case Ascertainment. CDH cases were ascertained using ICD-9-CM code 756.6, or ICD-
10 code Q79.0. Each case was classified as isolated or complex, with cases that had at least one 
concurrent anomalies listed on the National Birth Defects Prevention Network (NBDPN) list of 
major structural reportable defects (Table F) being classified as complex.49 
Exposure Assessment. The daily maximum of eight-hour running average ozone 
concentrations expressed as arithmetic mean in ppmv for 1998–2012 were obtained from the 
AQS.64 Clinical estimate of gestation and infant date of birth were used to determine calendar 
dates for the etiologically relevant time window for CDH development, that is, 4–12 weeks of 
gestation.65 The average exposure concentration for each mother was calculated for this time 
window at the population centroid of her residential address census tract at the time of birth 
using an inverse weighting approach.66 Specifically, population centroids were obtained from the 
www.census.gov website for 2000 and 2010 and then averaged. The spatial distance of each air 
monitor to each centroid was computed using the geodetic arc distance from the monitor using 
the GEODIST function in SAS 9.4. A spatial limit of influence of 100 km radius from the 
population centroid was applied. Maternal concentrations were then categorized into quartiles 
based on the distribution in infants without CDH. Equal temporal weights were assigned to all 
concentrations within the etiologically relevant time window.  
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Covariates’ Assessment. A directed acyclic graph (DAG) was constructed using DAGitty 
software version 2.367 to visualize the known relationships between the variables included in the 
study (Figure D.1). Covariates’ data were obtained from birth certificate records and included 
maternal age, race/ethnicity, education, marital status, smoking during pregnancy, prepregnancy 
body mass index (BMI), adequacy of prenatal care, parity, plurality, and infant sex. Maternal age 
was categorized in years as <20, 20–24, 25–29, 30–34, and ≥35; maternal race/ethnicity was 
categorized into white non-Hispanic, black non-Hispanic, Hispanic, and other; and maternal 
education was categorized into less than high school, high school equivalent, and more than high 
school. Maternal marital status was dichotomized into married and not married; maternal 
smoking during pregnancy was split into ‘no’ and ‘yes’; and adequacy of prenatal care was 
divided into ‘adequate’ and ‘not adequate’ based on the Kotelchuck index. Parity was classified 
into nulliparous and multiparous and plurality into singleton and multiple (twins, triplets, and 
higher-order). Prepregnancy BMI was categorized into underweight, normal weight, overweight, 
and obese. 
Statistical Analysis. Observations with missing or partial values for census tract number 
of maternal residential address at delivery were excluded from the analytic sample. Descriptive 
statistics were computed for all variables and chi-square tests of statistical independence were 
used to test if selected covariates varied by quartiles of ozone exposure. Multilevel Poisson 
regression was used to calculate crude and adjusted prevalence ratios of ambient ozone and risk 
of CDH, overall and stratified by its subtypes, isolated and complex. The GLIMMIX procedure 
in SAS 9.4 was used for this purpose in which a random effect was specified for the census tract 
of maternal address at delivery. The referent group in all models was the lowest quartile of 
exposure category. Since prepregnancy BMI was available only from March 2004 and after, 
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these analyses were repeated for this subset of data with the addition of prepregnancy BMI to 
each model. This analysis did not find prepregnancy BMI to be a confounder in the association 
between maternal exposure to ozone and CDH (p-values >0.10). Therefore, the results are 
presented for 1998–2012 and not separately for the subsample from 2004–2012. Backward 
stepwise regression was used to determine the covariates in the final model; a variable that was 
significant at 10% level was retained in the model. Sensitivity analyses were conducted using 
other windows of exposure besides 4–12 weeks of pregnancy including 0–12 weeks, 1–12 
weeks, 2–12 weeks, and 3–12 weeks. All analyses were conducted using SAS 9.4;68 hypothesis 
tests were two-sided with a 5% type I error rate. 
 
RESULTS 
The initial study population consisted of 3,209,775 live-born infants including 1,025 CDH cases 
during the 15–year study period. After excluding infants who had missing or incomplete data on 
census tract number, the final sample consisted of 3,039,685 infants including 981 cases. The 
mean (standard deviation) of all maternal exposure concentrations for ozone was 0.037 (0.008) 
ppmv. Among isolated CDH cases, more infants were in the highest quartile of exposure 
compared to other quartiles of exposure. For complex CDH cases, more infants were in quartile 
2 of exposure compared to other quartiles. White non-Hispanic and other race/ethnicity, age 
groups <20 and 20–24 years, mothers who smoked during pregnancy, mothers with adequate 
prenatal care, and multiparous women were more likely to be in the highest quartile of exposure 
compared to other quartiles. However, women 30 years and older, black non-Hispanic and 
Hispanic women, and multiple births were more likely to be in the lowest quartile compared to 
other quartiles of exposure (Table 3.1). 
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 We did not find an association between maternal exposure to ambient ozone 
concentration and CDH regardless of the etiologically relevant time windows (Tables 3.2 and 
D.1). The results were inconsistent in magnitude for overall, isolated, and complex, different 
etiologically relevant time windows, and exposure categories; none of these findings were 
significant. For complex cases, prevalence ratios of 1.16, 1.24, and 1.12 were found for maternal 
exposure to quartile 2 of ozone exposure during 1– 2, 3–12, and 4–12 weeks of pregnancy, 
respectively, but no increased prevalence for 1–12 or 2–12 weeks compared to the lowest 
quartile of exposure (Tables 3.2 and D.1).  
 
DISCUSSION 
This 15–year retrospective cohort study of over three million births in the State of Florida did not 
find an association between maternal exposure to ambient ozone concentration and CDH.  
Despite the null findings from this study on CDH, ambient ozone has been associated 
with increased risks for certain congenital heart defects, chromosomal anomalies, and limb 
reduction defects. A matched case-control study from Australia found 2.96 increased odds of 
pulmonary artery and valve defects for every 5ppb increase in ozone concentration for mothers 
who resided within six km distance of an air monitor.69 A 1987–1993 study based on the 
California Birth Defects Monitoring Program found 2.68 increased odds of aortic artery and 
valve defects in the highest quartile of ozone exposure compared to the lowest quartile.24 A 
1997–2005 study in Israel found 2.13 higher odds of chromosomal anomalies for highest versus 
lowest tertile of exposure.26 A Taiwanese matched case-control study found 1.39 higher odds of 
limb reduction defects for every 10 ppb increase in ozone concentration in preterm infants.27 
However, some studies have found inverse associations between maternal exposure to ambient 
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ozone and birth defects. A study in the San Joaquin valley of California found 42% lower odds 
of neural tube defects among infants born to mothers in the highest quartile compared to lowest 
quartile of exposure.70 Similarly, a population-based case-control study that used Texas Birth 
Defects Registry data found 36% lower odds of ventricular septal defects in highest quartile of 
exposure compared to the lowest quartile.28 
This study had a large sample size and was based on birth defects registry data that has 
higher sensitivity and positive predictive value and is more complete and accurate in ascertaining 
CDH cases than birth certificate data for CDH.46 Due to the diversity of population in Florida the 
study results may be generalizable to a similarly diverse population. However, the mean ozone 
concentration for the study period (0.037 ppmv) was lower than the national trend based on the 
annual 4th maximum of daily maximum eight hour average during the study period.31 Therefore, 
the results may be different in regions with higher ozone concentrations and more variability. 
Since the FBDR consists of data only for live-born infants with CDH, stillbirths and abortions 
(elective or spontaneous) that were affected by CDH and missed by the birth defects registry 
were not included in the study; therefore, the CDH cases are likely to be underestimated. This 
may especially be applicable in cases that were in the highest quartiles of the exposure since 
maternal exposure to ambient ozone has been found to be associated with reduced likelihood of a 
live birth.71 We used the daily maximum of eight-hour running average concentrations for ozone 
assessment. However, this may not be the appropriate averaging method for ozone assessment to 
examine its association with CDH. It is also not known if the effects of maternal exposure to 
ozone is acute or chronic. Additionally, in this study 100km radius from the population centroid 
of the census tract was stated as the spatial limit of exposure and maternal concentrations were 
averaged during the etiologically relevant time window of exposure. Maternal ozone 
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concentrations may vary depending on the choice of spatial and temporal limits and scales, 
thereby leading to uncertainties in estimates.66 Exposure misclassification could have biased the 
results toward the null. One of the reasons for this misclassification is that data on maternal 
residence were only available at the time of delivery which may not be the same residence during 
the etiologically relevant time window for CDH. However, if the mothers in our study behaved 
in a similar manner as in the National Birth Defects Prevention Study in Texas that found no 
evidence for differences in residential mobility between cases and controls72 then the probable 
effect of residential mobility on exposure misclassification may have been minimized and/or 
biased toward the null. A source of nondifferential covariate misclassification is self-reported 
maternal smoking during pregnancy that could have biased the results toward the null. Another 
study limitation is that we did not have data on maternal nutrient intake, especially vitamin A, 
which may be useful to identify the role of vitamin A in the relationship between maternal 
exposure to ambient ozone and CDH. 
 
CONCLUSIONS 
This study found no association between maternal exposure to ambient ozone during the first 
trimester and CDH in the State of Florida. Studies with better exposure data and inclusion of 
fetal losses may be needed. Case-control studies on gene-ozone and retinol-ozone interactions or 
maternal vitamin A status as a mediator in the relationship between maternal exposure to 
ambient ozone and CDH may shed some light in this area. 
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Table 3.1 Selected Maternal and Infant Characteristics Among Live Born Births in the State of Florida: 1998 – 2012, by Quartiles of 
Maternal Exposure to Ambient Ozone Concentration (ppm) during 4 -12 weeks of Gestation (N=3,039,685) 
  Total Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-Value 
    N (%) N (%) N (%) N (%)   
Congenital Diaphragmatic Hernia 
Not present 3,038,704  759,675 (25.0) 759,656 (25.0) 759,705 (25.0) 759,668 (25.0) 0.65 
Isolated 746 182 (24.4) 191 (25.6) 177 (23.7) 196 (26.3)  
Complexa 235 62 (26.4) 68 (28.9) 54 (23.0) 51 (21.7)  
Maternal age (years) 
<20 320,615 75,909 (23.7) 77,965 (24.3) 80,569 (25.1) 86.172 (26.9) <.001 
20–24 761,531 182,071 (23.9) 188,117 (24.7) 192,493 (25.3) 198,850 (26.1)  
25–29  818,126 202,696 (24.8) 205,328 (25.1) 205,524 (25.1) 204,578 (25.0)  
30–34 691,734 178,900 (25.9) 175,636 (25.4) 171,591 (24.8) 165,607 (23.9)  
35+ 447,497 120,293 (26.9) 112,824 (25.2) 109,714 (24.5) 104,666 (23.4)  
Maternal Race/Ethnicity 
White Non – Hispanic  1,452,568 321,309 (22.1) 355,730 (24.5) 378,126 (26.0) 397,403 (27.4) <0.001 
Black Non – Hispanic 564,896  150,388 (26.6) 139,041 (24.6) 136,355(24.1) 139,112 (24.6)  
Hispanic 901,796  259,802 (28.8) 234,918 (26.1) 214,961 (23.8) 192,115 (21.3)  
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Table 3.1 (Continued)       
Other 120,425  28,420 (23.6) 30,226 (25.1) 30,494 (25.3) 31,285 (26.0)  
Maternal Education 
< High School 405,432 655,208 (25.0) 654,918 (25.0) 655,759 (25.0) 656,862 (25.0) <0.001 
High School/Associate 
Degree 
1,499,321 
 
369,131 (24.6) 373,190 (24.9) 376,144 (25.1) 380,856 (25.4)  
> High School 1,123,426 
 
286,077 (25.5) 281,728 (25.1) 279,615 (24.9) 276,006 (24.6)  
Marital Status 
Single 1291,084  320,648 (24.8) 324263 (25.1) 322332 (25.0) 323841 (25.1) <0.001 
Married 1748255  439,168 (25.1) 435,576 (24.9) 437,514 (25.0) 435,997 (25.0)  
Maternal Smoking during Pregnancy 
No 2,779,747  707,364 (25.4) 697,776 (25.1) 691,316 (24.9) 683,291 (24.6) <0.001 
Yes 252,373  50,986 (20.2) 60,347 (23.9) 66,603 (26.4) 74,437 (29.5)  
Parity 
Nulliparous 2039,589 (67.4) 495,372 (24.3) 569,721 (27.9) 536,716 (26.3) 437,780 (21.5) <0.001 
Multiparous 988,498 (32.6) 260,240 (26.3) 186,934 (18.9) 220,691 (22.3) 320,633 (32.4)  
Receipt of Prenatal Care 
Not Adequate 703,966 (25.1) 175,188 (24.9) 175,787 (25.0) 174,839 (24.8) 178,152 (25.3) <0.001 
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Table 3.1 (Continued)       
Adequate 2,101,972 (74.9) 519,2 (24.7) 526,359 (25.0) 528,804 (25.2) 527,737 (25.1)  
Plurality 
Singleton 2,944,653  735,497 (25.0) 736,435 (25.0) 736,358 (25.0) 736,363 (25.0)  <0.001 
Multiple 94,957  24,405 (25.7) 23,456 (24.7) 23,557 (24.8) 23,539 (24.8)  
Infant Sex 
Male 1,555,924  389,123 (25.0) 389,112 (25.0) 388,907 (25.0) 388,782 (25.0) 0.93 
Female 1,483,719  370,791 (25.0) 370,796 (25.0) 371,014 (25.0) 371,118 (25.0)  
Note: Row percentages displayed 
P – values for X2 test of independence 
Frequencies may not add to the total due to missing data; percentages may not add to 100% due to rounding.  
A case that had associated birth defects listed on the National Birth Defects Prevention Network was categorized as complex.49  
 
 
 
 
 
 
 
 43 
 
 
 
Table 3.2 Association between Maternal Exposure to Ambient 
Ozone (ppm) during 4–12 weeks of pregnancy and Congenital 
Diaphragmatic Hernia Among Live Births in the State of 
Florida, 1998–2012 
Quartiles of Ambient Cadmium Prevalence Ratio (95% CI) 
Overall CDH  
2 vs 1 1.08 (0.90, 1.29) 
3 vs 1 0.95 (0.80, 1.15) 
4 vs 1 1.00 (0.84, 1.20) 
Isolated CDH  
2 vs 1 1.06 (0.86, 1.30) 
3 vs 1 0.97 (0.79, 1.20) 
4 vs 1 1.05 (0.86, 1.30) 
Complexa CDH  
2 vs 1 1.12 (0.60, 1.29) 
3 vs 1 0.88 (0.56, 1.22) 
4 vs 1 0.82 (0.73, 1.22) 
Note: Adjusted for infant sex, parity, maternal education, and plurality 
Abbreviations: CI = confidence interval, CDH = congenital diaphragmatic 
hernia 
aA case that had associated birth defects listed on the National Birth 
Defects Prevention Network was categorized as complex.49 
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CHAPTER FOUR 
MANUSCRIPT 3 
Maternal Exposure to Ambient Cadmium Levels as a Risk Factor for Congenital 
Diaphragmatic Hernia 
ABSTRACT 
BACKGROUND: Congenital diaphragmatic hernia (CDH) is a rare musculoskeletal birth defect 
with a prevalence of 2.61 per 10,000 in the United States. There is limited evidence for ambient 
air pollutants in the etiology of CDH in humans. 
OBJECTIVES: We investigated the role of maternal exposure to ambient cadmium as a risk 
factor for CDH (overall and stratified by isolated and complex subtypes) in Florida and whether 
maternal smoking during pregnancy was an effect modifier of this association.  
METHODS: We conducted a population-based, retrospective cohort study using data from the 
1999-2012 Florida Birth Defects Registry linked to the National Air Toxic Assessment database. 
Analyses included Chi–square tests; multilevel Poisson regression models to calculate measures 
of association between cadmium and CDH; and stratified analyses to examine effect 
modification by maternal smoking status. 
RESULTS: The study population consisted of 2,591,395 live births including 840 CDH cases. 
There was little evidence of an association between maternal exposure to ambient cadmium 
concentration and CDH. We did observe a 24% increased risk of CDH among isolated cases in 
the highest quartile of cadmium exposure (confidence interval [CI]: 1.00, 1.55). Maternal 
smoking during pregnancy was found to be an effect modifier among overall (prevalence ratio: 
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2.14, 95%CI: 1.04, 4.39) and isolated (prevalence ratio: 2.14, CI: 1.07, 5.57) cases in the highest 
quartile of exposure.  
CONCLUSIONS: Ambient cadmium concentration may be a risk factor for CDH among 
mothers who smoke during pregnancy. Smoking cessation and zinc and iron supplementation 
may mitigate the potential teratogenicity of cadmium. Further research is needed to unravel the 
role of this urban toxic in pregnancy. 
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INTRODUCTION 
Cadmium is one of the 30 urban toxics32 that has been has classified as a possible carcinogen by 
the International Agency for Research on Cancer.33 The major anthropogenic sources of 
particulate cadmium (elemental cadmium and cadmium oxide, sulfide, and chloride) are mining 
and smelting of zinc-bearing ores, burning of fossil fuels, fuel combustion, phosphate fertilizer, 
cement and nickel-cadmium batteries production, and municipal and sewage sludge 
incinerators.33 Cigarette smoke is an important source of inhaled cadmium.73 Due to its long half-
life of 15–20 years in the human body,35 cadmium can accumulate and lead to adverse outcomes. 
It has been found to cause a multitude of birth defects in animals including cleft palate,37 
diaphragmatic hernia, renal defects, anopthalmia, microphthalmia, anal atresia, undescended 
testes, and dysplastic ears.38 However, there is limited evidence for its teratogenicity in humans. 
Congenital diaphragmatic hernia (CDH), a rare musculoskeletal birth defect, is 
characterized by the herniation of the abdominal contents through a congenital defect in the 
diaphragm.8 It affects about 1 in 3,836 infants in the United States.1 Chromosomal abnormalities 
and single-gene disorders account for 15%–20% of CDH cases.12 Male sex, Caucasian race, 
advanced maternal5,45 and paternal ages,18 nulliparity,43 maternal smoking before and/or during 
pregnancy,5,74 periconceptional alcohol consumption,17 and prepregnancy obesity75 have been 
found to be associated with CDH. Maternal nutrient deficiences and drugs have also been 
proposed as possible risk factors for CDH. Specifically, deficiency of vitamin A, choline, 
cysteine, selenium, and magnesium deficiency,20 use of the immunosuppressant mycophenolate 
mofetil,21 and sulfonamide22 have been identified as risk factors for CDH in humans; non-
steroidal anti-inflammatory drugs has been identified in animals.23 
  Disruption of the retinoic acid (RA) pathway during lung morphogenesis13 is the primary 
mechanism indicated in the pathogenesis of CDH. This is most notable in CDH cases associated 
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with other major congenital anomalies, whereas in isolated cases only subtle disruptions are 
seen. The HERNIA study in the Netherlands found that infants with retinol levels <0.61 μmol/L 
have over 14-fold increased odds of CDH compared to infants with retinol levels above this 
level.14 Cadmium can potentially alter the levels of expression of genes involved in RA 
metabolism by inducing intracellular oxidative stress40 that may lead to the development of 
CDH.  
The objectives of this study were to investigate the degree to which maternal exposure to 
cadmium in ambient air is associated with increased risk of CDH and CDH subtypes in offspring 
and to assess if maternal smoking during pregnancy is an effect modifier of this association. The 
amount of cadmium in a cigarette can range from 1–2 μg, out of which 10% can be inhaled 
during smoking with 50% uptake into the lung.73 Smokers have been reported to have 4–5 times 
higher concentrations in blood than nonsmokers.33 Therefore, it is hypothesized that the 
association between maternal exposure to ambient cadmium levels and CDH may be higher in 
mothers who smoke during pregnancy compared to mothers who do not smoke during 
pregnancy. 
 
MATERIALS AND METHODS 
Study population. We conducted a population-based, retrospective cohort study of live-born 
infants using data from the 1999–2012 Florida Birth Defects Registry (FBDR). The FBDR is a 
passive, population-based birth defects surveillance system that includes data on infants born 
alive to Florida resident mothers on or after January 1, 1998. Cases include infants who have 
been diagnosed with one or more structural, genetic, or other specified birth outcomes, primarily 
identified using diagnostic codes present in clinical and administrative databases.48 This study 
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was reviewed and approved by the Institutional Review Boards at the University of South 
Florida and the Florida Department of Health. 
Case Ascertainment. CDH cases were ascertained using the International Classification 
of Diseases, 9th Edition, Clinical Modification (ICD-9-CM) code 756.6, or 10th Edition (ICD-10) 
code Q79.0. Each case was then classified into isolated or complex. An isolated CDH case was 
one in which the infant did not have any other anomalies listed on the National Birth Defects 
Prevention Network (NBDPN) list of major structural reportable defects (Table F).49 
Exposure Assessment. Data for cadmium concentrations were obtained from National Air 
Toxic Assessment (NATA) database for the years 1999, 2002, 2005, and 2011. NATA data are 
used by the Environmental Protection Agency (EPA) in collaboration with state, local and tribal 
agencies to track progress in reducing emissions of hazardous air pollutants by identifying and 
prioritizing air toxics, emission sources, and locations of elevated health risks in populations. 
Hourly emissions data are modeled to yield ambient air and exposure concentrations and risk 
estimates for each state, county, and census tract.76 Estimated annual average ambient 
concentration of cadmium (available as cadmium compounds:  cadmium oxide, cadmium 
sulfide, and cadmium chloride) in μg/m3 was obtained for each census tract.76 Concentrations for 
years not available from the NATA database were estimated using piecewise linear interpolation. 
Maternal exposure concentrations during the first 12 weeks of pregnancy were estimated as the 
average of the annual concentrations, weighted by the number of in each year. Exposure 
concentrations were then categorized into quartiles based on the distribution in infants without 
CDH.  
Assessment of covariates. A directed acyclic graph (DAG) was constructed using DAGitty 
software version 2.367 to visualize the relationships between the variables included in the study. 
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(Figure E.1). These covariates were obtained from the Florida Bureau of Vital Statistics and 
included maternal age, race/ethnicity, education, marital status, smoking during pregnancy, 
adequacy of prenatal care, parity, plurality, and infant sex. Maternal age was categorized in years 
as <20, 20–24, 25–29, 30–34, and ≥35; maternal race/ethnicity was categorized into white non-
Hispanic, black non-Hispanic, Hispanic, and other; and maternal education was categorized into 
less than high school, high school equivalent, and more than high school. Maternal marital status 
was dichotomized into married and not married; maternal smoking during pregnancy was split 
into ‘no’ and ‘yes’; and adequacy of prenatal care was divided into ‘adequate’ and ‘not adequate’ 
based on the Kotelchuck index. Parity was classified into nulliparous and multiparous and 
plurality into singleton and multiple (twins, triplets, and higher-order).  
Statistical Analysis. Maternal address at delivery geocoded at the census tract level were 
obtained from the Florida Bureau of Vital Statistics which were then linked to census tract level 
NATA data. Any birth certificates with missing or partial values for maternal census tract of 
residence were excluded since cadmium exposure could not be estimated. Descriptive statistics 
of exposure by quartiles of cadmium concentration and selected covariates were computed to 
describe the study population, and chi–square tests of statistical independence were used to 
assess statistical significance. We used multilevel Poisson regression models to estimate the 
association between CDH (overall and stratified by isolated and complex subtypes) and various 
levels of cadmium exposure, comparing each quartile to the lowest quartile. For this purpose, the 
GLIMMIX procedure in SAS 9.4 was used in which a random effect was specified for the census 
tract of maternal address at delivery. Backward stepwise regression was used to determine the 
covariates in the final model; a variable that was significant at 10% level was retained in the 
model. We then evaluated effect modification by maternal smoking status through stratified 
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analyses (overall and stratified by isolated and complex) and estimation of the relative excess 
risk due to interaction (RERI) and a measure of interaction on the multiplicative scale as 
recommended by Knol, VanderWeele 77 The confounders that were found to be significant in the 
main effects models were retained in the models used to assess effect measure modification. All 
analyses were conducted using SAS 9.4.68 
 
RESULTS 
Initial study population consisted of 3,055,500 live births for 1998–2012. After excluding infants 
whose birth certificates were missing or incomplete values for mother’s geocoded residential 
address the final sample consisted of 2,591,395 live births including 840 cases. The median 
cadmium exposure during the study period was 4.16 x 10-5μg/m3 (interquartile range [IQR] = 
2.65 x 10-5μg/m3). Cadmium exposure quartiles differed in their distribution of all selected 
maternal and infant characteristics except for infant sex (Table 4.1). There were more isolated 
CDH cases in the highest quartile (30%) compared to other quartiles and fewer complex CDH 
cases in the highest quartile of exposure (21.8%) compared to other quartiles. Women age <20 
years and black non-Hispanic women were more likely to be in the highest quartile compared to 
other quartiles. In contrast, women with less than high school education and who received 
inadequate prenatal care were more likely to be in quartiles 3 and 4, respectively. In the 
multiparous category, more mothers were in the lowest quartile compared to other quartiles. 
Among smokers and nonsmokers alike, though there was a significant difference in the 
distribution of exposure groups the percentages were nearly evenly distributed (Table 4.1). 
Among isolated cases, we found a 24% increased risk in the highest quartile of exposure 
compared to the lowest quartile; however, the lower limit of the confidence interval was unity 
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(Table 4.2). We found unclear evidence to detect an association between maternal exposure to 
ambient cadmium concentration and CDH. Based on the results from the analyses stratified by 
smoking status, maternal smoking during pregnancy was found to be an effect modifier in 
overall and isolated cases. Considering all cases, mothers who reported smoking during 
pregnancy and were in the highest quartile of exposure had a prevalence ratio of 2.14 for CDH 
compared to mothers who smoked during pregnancy and were in the lowest quartile of ambient 
cadmium (Table 4.3). Likewise, a prevalence ratio of 2.44 was noted for isolated cases among 
mothers who smoked during pregnancy and were exposed to the highest quartile of cadmium 
levels (Table 4.4) compared to mothers who smoked during pregnancy and were in the lowest 
quartile of the exposure. Furthermore, the estimated joint effect of maternal smoking during 
pregnancy and exposure to ambient cadmium concentration in the highest quartile and was 1.36 
and 1.48 times higher than the estimated joint effect of no maternal smoking during pregnancy 
and exposure to ambient cadmium concentration in the lowest quartile in overall and isolated 
cases, respectively (Tables 4.3 and 4.4).  
 
DISCUSSION 
Our study of 2,591,395 live-born infants in Florida during 1999–2012 failed to find 
evidence of an association between higher levels of maternal exposure to ambient cadmium 
concentration and CDH among overall and complex cases. However, among isolated cases, we 
observed a 24% increased risk of CDH in the highest versus lowest quartile of exposure that did 
not reach statistical significance. The study results further suggest that maternal smoking during 
pregnancy may modify the association between maternal exposure to cadmium and CDH. 
 52 
 
 Though there is sparse evidence of teratogenicity of cadmium in humans, laboratory 
experiments have demonstrated its teratogenic effects. Cadmium chloride injected into rats have 
been found to cause diaphragmatic hernia, anopthalmia, microphthalmia, anal atresia, 
hydronephrosis, undescended testes, dysplastic ears,38 and cleft palate.37 Another study in chick 
embryos, found the occurrence of limb and ventral body wall defects, exencephaly, 
anophthalmia, and midfacial cleft and hypoplasia78 Additionally, the Healthy Pregnancy, Healthy 
Baby Study in North Carolina found pregnant women with high blood cadmium concentration to 
have 72% higher odds of having a small-for-gestational age infant compared to women with low 
blood cadmium concentration.79  
A 1995–2002 study that used data from the CDC’s Linked Birth-Infant Death and Fetal 
Death files found 34% increased risk of CDH in mothers who smoked during pregnancy.5 The 
National Birth Defects Prevention Study (NBDPS) found 90% increased odds of Bochdalek 
CDH for periconceptional exposure to cigarette smoking.74 In contrast, among overall and 
isolated cases, we found that mothers who smoked during pregnancy and were in the highest 
quartile of cadmium exposure had more than two times higher risk of CDH. Furthermore, the 
joint prevalence risk of maternal smoking during pregnancy and highest quartile of ambient 
cadmium exposure was nearly 1.5 times greater than the joint effect of not smoking during 
pregnancy and the lowest quartile of ambient cadmium exposure, suggesting synergism between 
these two exposures. This is plausible because cadmium is a component of cigarette smoke and 
cadmium concentrations in blood of smokers can be 4–5 times higher than in nonsmokers.33  
The major strengths of this study are its large sample size and the use of population-based 
birth defects registry data that is more complete and accurate in ascertaining CDH cases than 
birth certificate data.46 Florida’s population is diverse in race/ethnicity and maternal nativity; 
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consequently, the study results may be more generalizable to other diverse populations. The 
CDH cases are likely to be underestimated because the FBDR contains data only for live-born 
infants with CDH; therefore, pregnancies that end in stillbirths and abortions (elective or 
spontaneous) and that were affected by CDH were not included in the study. One of the study 
limitations is that the exposure was assessed based on residential census tract and not based on 
locations and activities.80 This could have resulted in nondifferential misclassification of the 
exposure. Another source of exposure misclassification is availability of data on maternal 
residence only at the time of delivery and not during the etiologically relevant time window for 
CDH (first 12 weeks of pregnancy). However, an NBDPS study in Texas found a median 
distance of 3.5 miles for cases and 3.7 miles for controls for residential mobility during 
pregnancy with no evidence for differences between cases and controls.72 Given that ambient 
cadmium concentration was assessed at census tract level, if mothers in our study behaved 
similarly, the probable effect of residential mobility on exposure misclassification may be 
minimal and/or biased toward the null. Cadmium exposure is likely to be underestimated in 
mothers who consume cadmium-rich diets or have environmental/occupational exposures to 
cadmium because this was not measured in our study. The use of modeled data can 
underestimate or overestimate concentrations compared to monitoring data due to spatial 
uncertainties.76 Additionally, annual average exposure concentration values may be less 
informative than values available at a smaller temporal scale if the effect is more acute. Maternal 
smoking during pregnancy is based on self-report and is likely to be underestimated in all 
quartiles of the exposure. This may lead to nondifferential covariate misclassification. 
Collectively, limitations in the data that served as multiple sources of biasing measures of 
association between cadmium exposure and CDH towards the null could have contributed to this 
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study’s lack of statistically significant findings in its main effects analyses. Lastly, the relatively 
small sample size of CDH complex cases resulted in wide confidence intervals especially for 
effect modification analyses indicating uncertainties in estimates and insufficient power to detect 
an association if it exists. 
 
CONCLUSIONS 
This study adds evidence to the sparse literature on the teratogenic effects of ambient 
cadmium concentration. More importantly, this study suggests that in addition to the teratogenic 
effects of cigarette smoke the synergistic effect between smoking and exposure to ambient 
cadmium during pregnancy is important in the etiology of CDH. It has reported that chronic 
exposure to low concentration of cadmium can interfere with uptake of calcium, iron, copper, 
and zinc, especially in mothers who are smokers.81 Therefore, zinc supplementation 78 and 
adequate serum ferritin levels could potentially reduce the effect of cadmium.81 More studies are 
needed in humans to investigate the teratogenicity of ambient cadmium and its interaction with 
smoking and dietary factors in the etiology of CDH. 
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Table 4.1 Selected Maternal and Infant Characteristics Among Infants Born Alive in the State of Florida: 1999–2012, by Quartiles of 
Ambient Cadmium Levels (N=2,591,395) 
  Total Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-Value 
    N (%) N (%) N (%) N (%)   
Congenital Diaphragmatic Hernia 
Not present 2,590,555 647,878 (25.0) 647,493 (25.0) 647,587 (25.0) 647,597 (25.0) 0.09 
Isolated 643 155 (24.1) 148 (23.0) 147 (22.9) 193 (30.0)  
Complexa 197 46 (23.4) 55 (27.9) 53 (26.9) 43 (21.8)  
Maternal age (years) 
<20 274,178 65,581 (23.9) 67,555 (24.6) 65,948 (24.0) 75,094 (27.4) <0.001 
20–24 656,157 161,398 (24.6) 163,878 (25.0) 160,335 (24.4) 170,546 (26.0)  
25–29  694,118 177,039 (25.5) 174441 (25.1) 171545 (24.7) 171093 (24.6)  
30–34 585,452 148,431 (25.3) 145,025 (24.8) 150,611 (25.7) 141,385 (24.2)  
35+ 381,331 95,598 (25.1) 96,768 (25.4) 99,293 (26.0) 89,672 (23.5)  
Maternal Race/Ethnicity 
White Non – Hispanic  1,218,490 310,538 (25.5) 309,685 (25.4) 296,513 (24.3) 301,627 (24.8) <0.001 
Black Non – Hispanic 487,659 120,776 (24.8) 104,184 (21.4) 113,459 (23.4) 149,240 (30.6)  
Hispanic 781,287 192,901 (24.7) 207,915 (26.6) 212,161 (27.2) 168,310 (21.5)  
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Table 4.1 (Continued)       
Other 103,959 23,864 (23.0) 25,883 (24.9) 25,599 (24.6) 28,613 (27.5)  
Maternal Education 
< High School 370,530 80,395 (21.7) 99,202 (26.8) 99,312 (16.8) 91,621 (24.7) <0.001 
High School/Associate 
Degree 
1,277,382 323,644 (25.3) 320,244 (25.1) 310,351 (24.3) 323,143 (25.3)  
> High School 932,801 242294 (26.0) 235873 (25.3) 409663 (25.2) 414764 (24.6)  
Marital Status 
Single 1,116,567 278,781 (25.0) 274,785 (24.6) 267,979 (24.0) 295,022 (26.4) <0.001 
Married 1,474,541 369,232 (25.0) 372,853 (25.3) 379,720 (15.8) 352,736 (23.9)  
Maternal Smoking during Pregnancy 
No 2,371,813 594,846 (25.1) 589,582 (24.9) 593,193 (25.0) 594,192 (25.0) <0.001 
Yes 212,206 52,404 (24.7) 55,665 (26.2) 52,545 (24.8) 51,592 (24.3)  
Parity 
Nulliparous 1,859,007 362,329 (19.5) 457,826 (24.6) 567,228 (30.5) 471,624 (25.4) <0.001 
Multiparous 721,572 282,968 (39.2) 187,690 (26.0) 77,615 (10.8) 173,299 (24.0)  
Receipt of Prenatal Care 
Not Adequate 607,532 157,416 (25.9) 159,044 (26.2) 149,510 (24.6) 141,562 (23.3) <0.001 
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Table 4.1 (Continued)       
Adequate 1,770,362 447,362 (25.3) 430,351 (24.3) 443,207 (25.0) 449,442 (25.4)  
Plurality 
Singleton 2,509,778 627,840 (25.0) 627,324 (25.0) 627,535 (25.0) 627,079 (25.0) 0.03 
Multiple 81,558 20,216 (24.8) 20,357 (25.0) 20,241 (24.8) 20,744 (25.4)  
Infant Sex 
Male 1,326,020 331,117 (25.0) 331,711 (25.0) 331,162 (25.0) 332,030 (25.0) 0.22 
Female 1,265,333 316,955 (25.1) 315,973 (25.0) 316,614 (25.0) 315,791 (25.0)   
Note: Row percentages displayed 
P–values from a chi-square test of independence 
Frequencies may not add to the total due to missing data; percentages may not add to 100% due to rounding.  
aA case that had one or more additional birth defects listed on the National Birth Defects Prevention Network was categorized as complex.49 
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Table 4.2 Association between Ambient Cadmium Levels and Congenital Diaphragmatic 
Hernia Among Infants Born Alive in the State of Florida, 1999–2012 
Quartiles of Ambient Cadmium 
Adjusteda Prevalence Ratio 
(95% CI) 
Overall CDH   
2 vs 1  1.01 (0.83,1.23) 
3 vs 1  0.98 (0.80,1.19) 
4 vs 1  1.16 (0.96, 1.41) 
Isolated CDH   
2 vs 1  0.96 (0.77, 1.21) 
3 vs 1  0.94 (0.74, 1.18) 
4 vs 1  1.24 (1.00, 1.55) 
Complexb CDH   
2 vs 1  1.16 (0.77, 1.74) 
3 vs 1  1.03 (0.68, 1.57) 
4 vs 1  0.75 (0.45, 1.26)  
Note: Abbreviations: CI = confidence interval, CDH = congenital diaphragmatic hernia 
aAdjusted for infant sex, maternal education, and plurality 
bA case that had one or more additional birth defects listed on the National Birth Defects Prevention Network 
was categorized as complex.49 
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Table 4.3 Modification of the Effect of Ambient Cadmium Levels on Overall Congenital Diaphragmatic Hernia by Maternal Smoking Status During 
Pregnancy Among Infants Born Alive in the State of Florida, 1999–2012 
 
Quartile 1 Quartile 2 Quartile 3 Quartile 4 PR 
(95%CI) for 
Quartile 2 
within strata 
of Smoking 
PR 
(95%CI) for 
Quartile 3 
within strata 
of Smoking 
PR (95%CI) 
for Quartile 4 
within strata 
of Smoking 
 
N cases / 
noncases 
PR (95% 
CI) 
N cases / 
noncases 
PR (95% 
CI) 
N cases / 
noncases 
PR (95% 
CI) 
N cases / 
noncases 
PR (95% 
CI) 
   
Smoking 
(No) 
189/594,
657 
1.00 182/589,
400 
0.97 (0.79, 
1.19) 
180/593,
013 
0.93 (0.76, 
1.14) 
211/ 
593,981 
1.11 (0.91, 
1.36) 
0.97 
(0.79, 1.19)  
0.93 
(0.76, 1.14)  
1.11 
(0.91, 1.36) 
Smoking 
(Yes) 
12/52,39
2 
0.64 (0.35, 
1.18) 
20/55,64
5 
1.09 (0.68, 
1.73) 
19/52,52
6 
1.09 (0.68, 
1.75) 
25/51,5
67 
1.36 (0.88, 
2.11) 
1.70 
(0.81, 3.56)  
1.72 
(0.82, 3.63)  
2.14 
(1.04, 4.39)  
Measure of interaction on additive scale:                   RERI = 0.48                    RERI = 0.52                   RERI = 0.61 
Measure of interaction on multiplicative scale:          Ratio of PRs = 1.76        Ratio of PRs = 1.83        Ratio of PRs = 1.91 
Notes: Abbreviations: PR = prevalence ratio; CI = confidence interval; RERI = relative excess risk due to interaction 
Adjusted for infant sex, maternal education, and parity 
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Table 4.4 Modification of the Effect of Ambient Cadmium Levels on Isolateda Congenital Diaphragmatic Hernia by Maternal 
Smoking Status During Pregnancy Among Infants Born Alive in the State of Florida, 1999–2012 
 
 
Quartile 1 Quartile 2 Quartile 3 Quartile 4 PR 
(95%CI) 
for 
Quartile 2 
within 
strata of 
Smoking 
PR 
(95%CI) 
for 
Quartile 3 
within 
strata of 
Smoking 
PR 
(95%CI) for 
Quartile 4 
within strata 
of Smoking 
 
N cases 
/noncase
s 
PR (95% 
CI) 
 
N cases / 
noncases 
PR (95% 
CI) 
 
N cases / 
noncases 
PR (95% 
CI) 
 
N cases / 
noncases 
PR (95% 
CI)  
 
   
Smoking 
(No) 
146/594,
657 
1.00 131/589,
400 
0.90 (0.71, 
1.15) 
132/59,3
013 
0.89 (0.70, 
1.13) 
172/593,
981 
1.18 (0.94, 
1.48) 
0.90 (0.70, 
1.15) 
0.89 (0.70, 
1.13) 
1.18 (0.94, 
1.48) 
Smoking 
(Yes) 
9/52,392 0.61 (0.30, 
1.24) 
16/55,64
5 
1.15 (0.68, 
1.93) 
14/52,52
6 
1.06 (0.61, 
1.84) 
21/51,56
7 
1.48 (0.91, 
2.41) 
1.88 (0.80, 
4.39) 
1.76 (0.74, 
4.20) 
2.44 (1.07, 
5.57) 
Measure of interaction on additive scale:                  RERI = 0.64                        RERI = 0.56                       RERI = 0.69 
Measure of interaction on multiplicative scale:         Ratio of PRs = 2.09            Ratio of PRs = 1.95            Ratio of PRs = 2.06 
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Table 4.5 Modification of the Effect of Ambient Cadmium Levels on Complexa Congenital Diaphragmatic Hernia by Maternal Smoking Status 
During Pregnancy Among Infants Born Alive in the State of Florida, 1999–2012 
 
Quartile 1 Quartile 2 Quartile 3 Quartile 4 PR 
(95%CI) 
for 
Quartile 2 
within 
strata of 
Smoking 
PR 
(95%CI) 
for 
Quartile 3 
within 
strata of 
Smoking 
PR 
(95%CI) for 
Quartile 4 
within strata 
of Smoking 
 
N cases / 
noncases 
PR (95% 
CI) 
N cases / 
noncases 
PR (95% 
CI) 
N cases / 
noncases 
PR (95% 
CI) 
N cases / 
noncases 
PR (95% 
CI)  
   
Smoking 
(No) 
43/594,6
57 
1.00 51/589,4
00 
1.15 (0.76, 
1.76) 
48/593,0
13 
1.01 (0.65, 
1.56) 
39/593,9
81 
0.73 (0.43, 
1.24) 
1.14 (0.75, 
1.74) 
1.02 (0.66, 
1.59) 
0.78 (0.46, 
1.33) 
Smoking 
(Yes) 
 0.78 (0.24, 
2.54) 
0.96 (0.34, 
2.72) 
1.11 (0.43, 
2.88) 
0.85 (0.28, 
2.50) 
1.34 (0.29, 
6.22) 
1.10 (0.23, 
5.31) 
0.51 (0.07, 
3.88) 
Measure of interaction on additive scale:                   RERI = 0.03                   RERI = 0.32                        RERI = 0.34 
Measure of interaction on multiplicative scale:         Ratio of PRs = 1.07         Ratio of PRs = 1.41            Ratio of PRs = 1.49 
Notes: Abbreviations: PR = prevalence ratio; CI = confidence interval; RERI = relative excess risk due to interaction  
Adjusted for maternal education and marital status 
aA case that had one or more additional birth defects listed on the National Birth Defects Prevention Network was categorized as complex.49 
# # #   #
; # Numbers suppressed due to confidentiality reasons
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CHAPTER FIVE 
CONCLUSIONS AND RECOMMENDATIONS 
This study examined associations between ambient levels of two air pollutants, ozone and 
cadmium, and CDH, a musculoskeletal birth defect. An important finding is that, maternal 
smoking during pregnancy may modify the association between maternal exposure to ambient 
cadmium in air and CDH. Among mothers who smoked during pregnancy, maternal exposure to 
the highest quartile compared to lowest quartile of ambient cadmium in air during the first 
trimester was associated with more than two times higher risk for having an infant with CDH. 
This suggests that perinatal providers may need to focus on mothers who smoke during 
pregnancy especially if they live in areas with high cadmium concentrations. Another finding is 
that, maternal education of high school or less and multiple birth were identified as risk factors 
for CDH. Higher risk for this defect among mothers with high school or less education may 
reflect disparities in access to health care involving decisions regarding prenatal diagnostic tests 
or pregnancy termination. Qualitative studies on the potential role of maternal education in the 
etiology of CDH may be able to provide more information. Though studies have demonstrated 
increased risk for birth defects among multiple births57,82 the biologic plausibility for this 
association is unclear.  
 For this research, I used data from the FBDR, a passive, statewide, birth defects 
surveillance system that includes data on live-born infants only. It would have been more 
informative to have data on stillbirths and abortions for two reasons. First, inclusion of only live 
births could have underestimated the prevalence and mortality rates. Infants with a severe defect 
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may have been aborted or terminated. Secondly, if the infants who did not survive were those 
that were exposed to the highest quartile of ambient ozone or cadmium then we may have 
underestimated the magnitude of risk among these infants that could have biased the results 
toward the null. This may be more applicable to infants born to mothers in the highest quartiles 
of ozone exposure since maternal exposure to increased levels of ambient ozone has been found 
to be associated with reduced likelihood of a live birth.71 An important feature of the FBDR is its 
changing data sources for case ascertainment from 2007–2011. From 1998–2007, the FBDR 
consisted of data from the Agency for Health Care Administration (AHCA) hospital inpatient 
and ambulatory discharge databases, Regional Perinatal Intensive Care Centers’ data, CMS Early 
Steps, and serve-related minimum datasets (MDS). By 2011, the data sources included AHCA 
hospital inpatient, ambulatory, and emergency department discharge databases and infant death 
certificates. This resulted in 12.6% reduction in the ability of the FBDR to capture CDH cases.54 
Another limitation of this research was that, there were no data on procedures performed or 
severity of the defect. It would have been useful to have this information to determine the 
association of these factors and neonatal and one-year mortality.  
 There is growing evidence that air pollution plays an important role in fetal development 
and growth and birth outcomes. Ozone has been found to be risk factors for low birth weight, 
intra-uterine growth restriction,30 and birth defects such as aortic artery and valve defects, 
pulmonary artery and valve anomalies,24 oral clefts, chromosomal anomalies,26 and limb 
reduction defects.27 In addition to this, high ozone levels can decrease sperm concentration and 
average sperm count that may have a potential role in the etiology of CDH associated with 
chromosomal anomalies. Though there is limited evidence for the teratogenicity of cadmium 
compounds, animal studies have found that it can damage primary spermatocytes, decrease 
 64 
 
oocyte formation, and cause skeletal and neurological defects,34 cleft palate,37 diaphragmatic 
hernia, renal defects, anopthalmia, microphthalmia, anal atresia, undescended testes, dysplastic 
ears,38 and low fetal weight.34  
This research adds to the sparse literature on the role of environmental exposures in 
etiology of CDH in humans especially the synergistic effect of maternal exposure to ambient 
cadmium in the highest quartile and maternal smoking during pregnancy among overall and 
isolated cases. However, there are certain limitations of this research that can be the focus of 
future studies. The current research focused on assessing maternal exposure during the first 12 
weeks of pregnancy. However, since mechanisms are poorly understood, the exact window for 
vulnerability of the fetus to the teratogenic effects exposures to either ambient ozone or cadmium 
is unknown. Furthermore, there is ambiguity regarding the dose and duration of the exposure that 
may cause an effect, including whether any effect may be due to acute or chronic exposures. A 
related limitation concerns the temporal distribution summary value used from the measured 
concentration data.  For the ozone study, the daily maximum of eight-hour running average was 
used here to assess maternal exposure to ambient ozone; that metric is available in the 
monitoring network data because it is used to assess NAAQS compliance. However, that statistic 
and averaging time may not be best for teratogenic effects. More broadly, the choice of spatial 
and temporal limits and scales in the exposure assessment could have led to uncertainties in 
estimates since maternal ozone concentrations may vary depending on these choices.66 Maternal 
concentrations of both ambient ozone and cadmium were not assessed at the individual level that 
could have led to nondifferential misclassification of the exposure that could have biased the 
results toward the null. A possible approach to overcome this limitation is the use of personal 
monitoring and/or biomarkers. This approach is, however, impractical and expensive for birth 
 65 
 
defects’ studies due to the low prevalence and necessity to follow thousands of mothers to 
achieve sufficient statistical power to detect an association if it exists. Furthermore, it is not clear 
which biomarker would be most appropriate for ambient ozone or cadmium exposures. The 
current study is limited by the absence of information regarding the potential ability of ambient 
ozone and cadmium to disrupt the retinoic acid pathway that could lead to the development of 
CDH. Analysis from case-control studies using maternal/infant retinol status as a mediator in the 
association between maternal exposure to ambient ozone and cadmium and CDH may reveal a 
possible relationship between ozone-retinol-CDH and cadmium-retinol-CDH. Pollutants do not 
exist in isolation. Multipollutant models may demonstrate the interactions between various 
pollutants and their associations with CDH. Gene-environment studies may be able to test gene-
ozone/cadmium and retinol–ozone/cadmium interactions. More studies are needed to determine 
the interaction of ambient cadmium, smoking, and dietary factors in the etiology of CDH. Future 
research may need to focus on other criteria air pollutants and urban toxics, and mixtures of 
pollutants that are potentially detrimental to normal development of the diaphragm.  
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APPENDICES 
 
APPENDIX A. LITERATURE REVIEW  
Structure and Embryology of the Diaphragm 
The diaphragm, a musculotendinous, dome-shaped structure that separates the thoracic and 
abdominal contents, is the primary muscle of respiration, specifically inspiration. It is the muscle 
involved in expulsive acts including sneezing, coughing, laughing, crying, vomiting, urination, 
defecation, or the delivery of an infant.83 Its peripheral part consists of muscular fibers that 
originate from the circumference of the thorax and are inserted into a central tendon. According 
to their origin, these muscular fibers may be grouped into three parts - sternal, costal, and 
lumbar. Noteworthy are the lumbar, tendinous structures that originate from the lumbar vertebrae 
that are called crura.83  
The diaphragm develops between 4–12 weeks of gestation65 and is derived from the 
following structures: 
1. The septum transversum, a mesodermal structure which forms the central tendon of the 
diaphragm;84 
2. The two pleuroperitoneal membranes that fuse with the mesentery of the esophagus and 
septum transversum by 7th week of gestation to close the connection between the 
thoracic and abdominal cavities giving rise to the primordial diaphragm.84,85 
3. During weeks 9-12 of gestation, muscular components are formed from somites at C3–
C5.65,85 The costodiaphragmatic recesses that give rise to the dome -shaped structure of 
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the diaphragm are formed from the extensions of the pleural cavities into these muscular 
components.84 
4. Muscle fibers that grow into the mesentery of the esophagus that develops into the crura 
of the diaphragm.84 
Congenital diaphragmatic hernia 
CDH is the herniation of the abdominal contents through a congenital defect in the 
diaphragm.8 
Anatomically, CDH can be broadly classified into:  
1. Posterolateral (Bochdalek) hernia that results from defect of the pleuroperitoneal folds 
(PPF) or failure of the folds and transverse septum with the intercostal muscles.84 It 
accounts for 90% of the CDHs and is common on the left side of the body9 (about 85% of 
posterolateral CDH is on the left, 10% right, and 5% are bilateral).12  
2. Nonposterolateral hernia results from a defect in fusion of the transverse septum to the 
lateral body wall.  About 10% of the CDH are of this variety84 and can be classified into 
anterior and central types. The anterior type is labeled Morgagni -Larrey type if the 
defect is positioned para- or retrosternal. The central type may co- occur with a group of 
birth defects referred to as Pentalogy of Cantrell.86  
Diaphragmatic eventration that can coexist with and/or misdiagnosed as a Bochdalek hernia is 
incomplete muscularization of the diaphragm resulting in a thin membranous sheet of tissue.  
All types of CDH can present with a sac covering the herniated abdominal contents.12 
CDH can be also be classified into isolated or complex/non-isolated. About 50%–60% of 
cases are isolated, whereas the rest co-occurs with other congenital anomalies, chromosomal 
abnormalities, or single-gene anomalies.9 The most common, co-occurring defect condition is a 
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congenital heart defect, which that occurs in 20% of the cases.10 Other co-occurring defects 
include, orofacial, or and body wall defects.11 About 10% of all individuals with CDH have a 
chromosome abnormality and the most common are trisomy 18 and isochromosome 12p.12  
Diagnosis of CDH 
The severity of CDH symptomatology depends primarily on the degree of pulmonary 
hypoplasia and severity of pulmonary hypertension. About 2/3rd two-thirds of infants with CDH 
are diagnosed prenatally.10,47 At birth, these infants present with respiratory failure; however, 
about 5–20% of the cases can present beyond the neonatal period, as late as five years of life, 
with the symptomatology differing from those presenting at birth.87 The late-onset symptoms 
include acute onset of respiratory or gastrointestinal distress, abdominal pain due to chronic 
intestinal obstruction, or and pleural effusion. Furthermore, about 1% of individuals are 
completely asymptomatic and the defect may be discovered accidently on imaging studies.87 
Treatment of CDH 
1. The treatment of severe CDH with fetal endoscopic tracheal occlusion has been found to 
increase survival from 24% to 49% in left sided cases and from 0% to 35% in right cases 
in comparison to standard care.47 
2. In moderate-to-severe CDH, surgical repair is delayed by 1–2 weeks until the infant has 
been stabilized and pulmonary vascular activity has decreased or resolved. Mild 
pulmonary hypertension and low-risk defects in CDH infants can be repaired earlier but 
mostly are delayed for 24–48 hours because the period of relative stability in the first day 
of life can be followed by respiratory difficulties and worsening of the pulmonary 
hypertension.47  
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3. ECMO is primarily used to stabilize the CDH infant during the time of maximal 
pulmonary vascular reactivity when standard therapy fails. 47 
Prognosis 
Survival rates of infants with CDH can depend on whether the defect is isolated or not. 
The presence of associated anomalies, especially congenital heart disease, Fryns syndrome, or 
Trisomy 18, is an indicator of high mortality and morbidity.12 The prognosis also depends on the 
size of the diaphragmatic defect, degree of pulmonary hypoplasia, and severity of pulmonary 
hypertension with larger defects, and severe pulmonary hypoplasia and hypertension indicative 
of poorer prognosis.12 Herniation of the liver into the chest is also a poor prognostic factor with 
35% survival rates in cases with liver herniation compared to 93% cases without the herniation. 
Additionally, liver herniation is highly predictive of the need for ECMO with 80% of them 
requiring this procedure compared to those without liver herniation.47 
Infants who survive can have significant bronchopulmonary dysplasia;88 higher rates of 
asthma, pulmonary infections, chronic pulmonary hypertension;47 neurodevelopmental deficits– 
delays in neurocognitive and language skills, up to one-month delay in structural brain 
development, sensorineural hearing loss;89,90 gastroesophageal reflux requiring medical treatment 
or even fundoplication; and high metabolic demands leading to nutritional deficiencies and poor 
growth.47  
Biologic Mechanism for the Development of CDH  
The primary mechanism proposed for the development of CDH is the disruption of the 
retinoic acid (RA) pathway during lung morphogenesis.13 The RA pathway hypothesis is 
demonstrated by decreased levels of retinol in human infants with CDH. Infants with retinol 
levels <0.61 µmol/L have over 14.11-fold higher increased odds of CDH (95% confidence 
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interval [CI]: 1.95, 102.00) compared to infants with retinol levels above this level.14 The 
disruption in the RA signaling pathway is primarily found in cases associated with major 
congenital anomalies whereas in isolated cases only subtle disruptions are seen. 
Epidemiologic and Laboratory Evidence  
Little is known about the etiology of CDH. It is known to result from chromosomal and 
genetic syndromes like Trisomy 18 and Pallister syndrome, but these account for only 10%–15% 
of the cases of CDH.15 The risk for a subsequent pregnancy to be affected has been estimated to 
be 2%.16 Sociodemographic characteristics that have been linked with CDH include maternal 
smoking and alcohol consumption during pregnancy,5,17 male sex, maternal Caucasian race, 
maternal age beyond over 40 years,5 increased paternal age,18 prepregnancy obesity,19 and parity. 
Environmental factors and dietary factors have been proposed as possible risk factors for CDH. 
Deficiency of vitamin A, choline, cysteine, selenium, and magnesium20 and intake of the 
immunosuppressant mycophenolate mofetil21 and sulfonamide22 have been identified as risk 
factors for CDH in humans, and non-steroidal anti-inflammatory drugs in animals.23 First 
trimester antifungal use has been associated with 1.88 higher, but non-significant, risk for 
CDH.91  
 The presence of associated anomalies such as congenital heart defects,4,47,92 single gene-
disorders like Fryns syndrome, and chromosomal anomalies such as Trisomy 1847, being 
African-American,3,4 and low birthweight45,93 have been associated with an increased risk for 
infant mortality among CDH infants.4  
Ozone 
Ozone is a highly reactive, colorless, and odorless gas made of three oxygen atoms. It is a 
criteria air pollutant that is the main component of photochemical smog.62 It is a secondary 
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pollutant since it is the product of reactions between primary pollutants and other elements in the 
atmosphere; volatile organic compounds (VOCs) and nitrogen oxides (NOx) react in the 
presence of heat and sunlight to form ozone. VOCs are emitted by a variety of sources, including 
motor vehicles, chemical plants, refineries, and other factories whereas NOx is emitted by motor 
vehicles, electric power plants, and other combustion sources. Morning rush hour traffic is a 
major source of NOx and VOC’s. In humans, it can persist for up to 18 hours after the 
exposure.62 
The U.S. Environmental Protection Agency (EPA) has set up standards for the criteria air 
pollutants, including ozone, under the Clean Air Act. There are two types of national ambient air 
quality standards: primary and secondary. Primary standards take into account public health 
protection whereas the secondary standard is concerned with “public welfare protection that 
includes protection against decreased visibility and damage to crops, vegetation, and buildings”. 
The 2015 primary and secondary standards for ozone is 0.07ppm for 8 hours.62  
Ozone has been found to be a risk factor for certain birth defects like congenital heart 
defects like aortic artery and valve defects, pulmonary artery and valve anomalies, and 
conotruncal defects.24 It is associated with adverse reproductive and fetal outcomes including 
low birth weight, intra-uterine growth retardation.30 
Cadmium  
Cadmium is one of the 30 urban toxics32 that has been has classified as a possible 
carcinogen by the International Agency for Research on Cancer.33 The major anthropogenic 
sources of particulate cadmium (as elemental cadmium and cadmium oxide, sulfide, and 
chloride) are burning of fossil fuels like coal or oil, secondary smelters, fuel combustion, 
phosphate fertilizer manufacture, and municipal and sewage sludge incinerators.33 Cigarette 
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smoke and ingestion of contaminated food and water are other sources of cadmium.34 Due to its 
long half-life of 15 – 20 years in the human body35 cadmium can accumulate and cause a variety 
of adverse outcomes. The bioaccumulation of cadmium occurs in the liver and kidneys that 
together constitute approximately 85% of the burden of the metal in the body. In fact, the kidney 
is regarded as the “sentinel of cadmium toxicity”.94 It can cause DNA damage in primary 
spermatocytes and also decrease oocyte formation.95 It has been found to cause a multitude of 
birth defects in animals including cleft palate,37 diaphragmatic hernia, renal defects, anopthalmia, 
microphthalmia, anal atresia, undescended testes, and dysplastic ears.38 However, there is no 
evidence for teratogenic effects of cadmium in humans. 
Study Rationale 
Experimental studies in rats have found decreased serum retinol levels in those exposed 
to ozone.39  This evidence combined with evidence from the Netherlands’ study depicting 
decreased retinol levels in infants with CDH14 suggests a possible role for ozone as a risk factor 
for CDH. A possible mechanism for cadmium leading to the development of CDH is that it can 
alter the levels of expression of the genes involved in RA metabolism mostly by inducing 
oxidative stress40 leading to the development of CDH.  
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APPENDIX B. SENSITIVITY ANALYSES OF STUDY DESIGN 
INTRODUCTION 
Prior to conducting analyses for manuscripts two and three, I did sensitivity analyses of study 
design by comparing population-based retrospective cohort with case-control study matched on 
propensity scores and case-control study matched on entropy balanced weights to determine the 
study design with the most precise estimates. For this purpose, it was decided to examine the 
association between maternal exposure to ambient cadmium and overall CDH. 
A propensity score is the probability of the exposure conditional on observed baseline 
covariates. In a case-control study matched on propensity score the distribution of the baseline 
covariates is similar in exposed and unexposed groups conditional on the propensity score.96 
Therefore, it is used to reduce the effects of confounding. 
Entropy balancing is a multivariate reweighting method wherein the control group is 
reweighted to match the moments (mean, variance, or skewness) of the covariate distribution in 
the treatment group. This results in balanced covariate distribution between the groups.97 The 
entropy balancing method is easier to use and leads to better covariate balance compared to 
propensity score adjustments.97 
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METHODS 
Study population 
Population-based retrospective cohort. The study population, case ascertainment, exposure 
assessment, and covariate assessment were exactly the same as for manuscript three except that 
maternal history of chronic hypertension was an additional covariate.  
Case-control matched on propensity scores. Noncases were matched to cases on 1:2 ratio 
since it has been reported that the optimal matching ratio for propensity score matching is 1:1 or 
1:2.98 Case ascertainment, exposure assessment, and covariate assessment were exactly the same 
as for the population-based retrospective cohort study design. 
Case-control matched on reweighting entropy balanced weights. Noncases were 
randomly selected on a 4:1 ratio from the population-based retrospective cohort study. Case 
ascertainment, exposure assessment, and covariate assessment were exactly the same as for the 
population-based retrospective cohort study design. 
Statistical Analysis 
Population-based retrospective cohort. Multilevel Poisson regression models were used 
to estimate the association between overall CDH and various levels of cadmium exposure, 
comparing each quartile to the lowest quartile. For this purpose, the SAS 9.4 GLIMMIX 
procedure was used in which a random effect was specified for the census tract of maternal 
address at delivery. All covariates were retained in the model so that the analysis could be 
compared to the analyses for propensity scores and entropy balanced weights. Multiple 
imputation was used to account for missing data. Analyses were conducted with and without 
imputed datasets and the results were compared.  
Case-control study matched on propensity scores. Propensity scores (the probability of 
the being exposed to different quartiles of ambient cadmium conditional on covariates in the 
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study) were computed using proc LOGISTIC after using multiple imputation to account for 
missing data. Using the SAS macro for propensity score matching by Fraeman KH (2010)99 
noncases were matched to cases on a 2:1 ratio for which purpose using a caliper width of 0.10 
(that is, the allowable absolute distance difference between the propensity scores for cases and 
noncases was 0.10) was used. Covariate balance were assessed before and after matching and no 
conditioning was done because the difference in the odds ratios between each covariate and the 
exposure was minimal pre-and post-matching. A mixed effects logistic regression model 
(random effect was specified for the census tract of maternal address at delivery) using SAS 9.4 
GLIMMIX procedure was then used to examine the association between ambient cadmium and 
overall CDH after adjusting for the propensity scores. The results were then compared between 
models with and without imputation. 
Case-control matched on reweighting entropy balanced weights. All cases were included 
in the study. Noncases were then randomly selected on a 4:1 (noncases: cases) ratio from the 
population-based retrospective cohort study. Entropy balancing was then used to reweight the 
dataset to balance the covariate distribution among cases and noncases. The STATA package, 
ebalance, was used to compute the entropy balanced weights.97 Since all the covariates were 
categorical only the first moment (that is, mean) could be used to calculated the weights. These 
weights were specified to the svyset [pweight=] command which was then used in a mixed 
effects logistic regression model (random effect was specified for the census tract of maternal 
address at delivery) to reweight the sample to examine the association between ambient 
cadmium in air and overall CDH. Multiple imputation was used for missing data and results were 
compared between models with and without multiple imputation. 
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The study with the least standard error of the prevalence/odds ratio was used to determine 
the best study design in terms of precise estimates. 
 
RESULTS 
For models without multiple imputation, the population-based retrospective cohort study had the 
lowest standard error (0.11) (Table B.1).  For models that used multiple imputation to account 
for missing data both the population-based retrospective cohort study and case-control matched 
on propensity scores had the lowest standard errors that were the identical (0.10) for all quartiles 
of cadmium exposure (Table B.2). For the case-control study matched on entropy balanced 
weights, there was minimal/no difference in the standard errors between models with and 
without imputation (Tables B.1 and B.2). 
 
CONCLUSION 
Based on the standard errors it was decided to use the population-based retrospective cohort 
study design to examine the association between ambient ozone (manuscript two) and cadmium 
(manuscript three) in air and CDH because it gave the most precise estimates for models with 
and without multiple imputation. 
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Table B.1 Comparison of Study Designs for the Association between Ambient Cadmium Levels and Congenital 
Diaphragmatic Hernia (Results from Complete Case Analyses) 
Cadmium 
categories 
Population-based 
Retrospective Cohort 
Case-control study matched on 
propensity scores 
Case-control reweighted by 
entropy balanced weights 
Multilevel Poisson regression Multilevel logistic regression Weighted multilevel logistic 
regression 
Prevalence Ratio 
(95% CI) 
SE Odds Ratio 
(95% CI) 
SE Odds Ratio 
(95% CI) 
SE 
 N = 2,323,592 N = 2,199 N = 3,756 
Quartile 2 vs 1 0.99 (0.80,1.22) 0.11 0.42 (0.22,0.82) 0.14 1.03 (0.81,1.30) 0.12 
Quartile 3 vs 1 1.01 (0.81,1.25) 0.11 1.40 (0.68,2.88) 0.14 1.03 (0.80,1.31) 0.13 
Quartile 4 vs 1 1.13 (0.92, 1.40) 0.11 0.52 (0.25,1.10) 0.14 1.16 (0.91,1.46) 0.14 
CI = confidence interval, SE = standard error 
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Table B.2 of Study Designs for the Association between Ambient Cadmium Levels and Congenital 
Diaphragmatic Hernia (Results from Multiple Imputation) 
Cadmium 
categories 
Population-based 
Retrospective Cohort 
Case - control study matched on 
propensity scores 
Case -control reweighted by 
entropy balanced weights 
Multilevel Poisson 
regression 
Multilevel logistic regression Weighted Multilevel logistic 
regression 
Prevalence Ratio 
(95% CI) 
SE Odds Ratio 
(95% CI) 
SE Odds Ratio 
(95% CI) 
SE 
 N = 2,591,395 N = 2,520 N = 4,200 
Quartile 2 vs 1 1.02 (0.83,1.24) 0.10 0.95 (0.78,1.16) 0.10 1.04 (0.83,1.31) 0.12 
Quartile 3 vs 1 1.02 (0.83,1.25) 0.10 0.92 (0.75,1.12) 0.10 1.01 (0.80,1.27) 0.12 
Quartile 4 vs 1 1.19 (0.98,1.45) 0.10 1.12 (0.92,1.36) 0.10 1.20 (0.96,1.50) 0.14 
CI = confidence interval, SE = standard error 
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APPENDIX C 
SUPPLEMENTAL MATERIALS FOR MANUSCRIPT 1 
Table C.1 Prevalence Ratios of Congenital Diaphragmatic Hernia by Prepregnancy Body Mass Index in the State of 
Florida: March 2004–December 2012 (N = 1,963,766) 
Prepregnancy Body Mass Index CDH 
N (%) 
No CDH 
N (%) 
Prevalence Ratea 
(95% CI) 
Adjustedb Prevalence 
Ratio (95% CI) 
Normal weight 278 (43.9) 919797 (46.9) 3.02 (2.66-3.37) 1.00 
Underweight 82 (13.0) 219981 (11.2) 3.73 (2.92-4.53) 0.83 (0.64-1.06) 
Overweight 126 (19.9) 450316 (22.9) 2.80 (2.31-3.28) 1.09 (0.88-1.34) 
Obese 147 (23.2) 373039 (19.0) 3.94 (3.30-4.57) 0.78 (0.64-0.96) 
Notes: CDH = congenital diaphragmatic hernia, CI = confidence interval  
a Congenital diaphragmatic hernia cases per 10,000 live births 
bAdjusted for maternal age, race/ethnicity, education, smoking during pregnancy, marital status, parity, receipt of prenatal care, plurality, 
and infant sex. 
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Table C.2 Prevalence Ratios of Congenital Diaphragmatic Hernia (Isolated and Complex) by 
Prepregnancy Body Mass Index in the State of Florida: March 2004–December 2012 (N= 1,963,766) 
 
 Isolated CDH Complexa CDH  
Prepregnancy Body Mass 
Index 
Cases 
N (%) 
Adjustedb 
Prevalence Ratio 
(95% CI) 
Cases 
N (%) 
Adjustedb 
Prevalence Ratio 
(95% CI) 
 
Normal weight 208 (44.7) 1.00 70 (41.7) 1.00  
Underweight 56 (12.0) 0.90 (0.67-1.21) 26 (15.5) 0.67 (0.43-1.05)  
Overweight 91 (19.6) 1.12 (0.87-1.43) 35 (20.8) 1.00 (0.67-1.51)  
Obese 110 (23.7) 0.77 (0.64-0.97) 37 (22.0) 0.82 (0.54-1.23)  
Notes: CDH = congenital diaphragmatic hernia, CI = confidence interval  
aA case that had associated birth defects listed on the National Birth Defects Prevention Network was categorized as 
complex.49 
bAdjusted for maternal age, race/ethnicity, education, smoking during pregnancy, marital status, parity, receipt of prenatal 
care, plurality, and infant sex. 
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Table C.3 Neonatal and One-Year Survival Among Live-born Congenital Diaphragmatic Hernia Cases by Prepregnancy Body Mass 
Index in Florida: March 2004–December 2012 (N= 1,963,766) 
 Neonatal Period First Year of Life 
 All Cases Isolated CDH Complexa CDH All Cases Isolated CDH Complexa CDH 
Characteristics Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI)  
Normal weight 1.00 1.00 1.00 1.00 1.00 1.00 
Underweight 0.46 (0.28-0.78) 0.50 (0.25-0.98) 0.33 (0.14-0.77) 0.50 (0.33-0.76) 0.46 (0.27-0.81) 0.53 (0.26-1.06) 
Overweight 1.15 (0.64-1.04) 1.40 (0.64-3.08) 0.91 (0.37-2.23) 1.34 (0.84-2.13) 1.44 (0.76-1.53) 1.17 (0.59-2.30) 
Obese 0.90 (0.55-1.46) 0.93 (0.55-1.75) 0.71 (0.31-1.60) 1.01 (0.68-1.52) 0.91 (0.54-2.72) 1.36 (0.66-2.81) 
Notes: CDH = congenital diaphragmatic hernia, HR = Hazard Ratio, CI = confidence interval  
aA case that had associated birth defects listed on the National Birth Defects Prevention Network was categorized as complex.49 
All models adjusted for maternal age, race/ethnicity, education, smoking during pregnancy, marital status, parity, receipt of prenatal care, plurality, infant 
sex, delivery route, gestational age and birthweight. 
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APPENDIX D.  
SUPPLEMENTAL MATERIALS FOR MANUSCRIPT 2 
Table D.1 Sensitivity Analyses of the Association between Maternal Exposure to Ambient Ozone (ppmv) and 
Congenital Diaphragmatic Hernia Among Live Births in the State of Florida, 1998–2012 by Different 
Etiologically Relevant Time Windows 
 
0 – 12 weeks 
of Pregnancy 
1 – 12 weeks   
of Pregnancy 
2– 12 weeks   
of Pregnancy 
3– 12 weeks   
of Pregnancy 
Quartiles of Ambient Cadmium 
Prevalence Ratio 
(95% CI) 
Prevalence 
Ratio (95% CI) 
Prevalence Ratio 
(95% CI) 
Prevalence Ratio 
(95% CI) 
Overall CDH     
2 vs 1 1.05 (0.87, 1.25) 1.00 (0.84, 1.19) 1.03 (0.86, 1.23) 1.06 (0.89, 1.28) 
3 vs 1 0.96 (0.80, 1.15) 1.00 (0.84, 1.20) 0.92 (0.77, 1.10) 0.96 (0.80, 1.16) 
4 vs 1 1.05 (0.88, 1.26) 0.96 (0.80, 1.15) 0.94 (0.78, 1.12) 0.98 (0.82, 1.17) 
Isolated CDH     
2 vs 1 1.01 (0.82, 1.24) 0.99 (0.81, 1.22) 1.05 (0.86, 1.29) 1.01 (0.82, 1.24) 
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 Table D.1 (Continued)     
3 vs 1 0.94 (0.76, 1.16) 1.04 (0.84, 1.27) 0.93 (0.75, 1.14) 0.93 (0.75, 1.15) 
4 vs 1 1.06 (0.86, 1.30) 1.04 (0.85, 1.28) 1.00 (0.82, 1.23) 1.00 (0.82, 1.22) 
Complexa CDH     
2 vs 1 1.16 (0.80, 1.68) 0.99 (0.73, 1.22) 0.92 (0.64, 1.32) 1.24 (0.86, 1.78) 
3 vs 1 1.00 (0.68, 1.47) 0.88 (0.79, 1.39) 0.86 (0.60, 1.25) 1.05 (0.72, 1.53) 
4 vs 1 1.02 (0.69, 1.52) 0.69 (0.76, 2.73) 0.70 (0.47, 1.04) 0.90 (0.62, 1.33) 
Notes: Adjusted for infant sex, maternal education, plurality, and parity 
Abbreviations: CI = confidence interval, CDH = congenital diaphragmatic hernia 
aA case that had associated birth defects listed on the National Birth Defects Prevention Network was categorized as complex.49 
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Figure D.1 Directed Acyclic Graph of the Association between Maternal Exposure to Ambient Ozone Concentration and Congenital 
Diaphragmatic Hernia
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APPENDIX E.  
SUPPLEMENTAL MATERIALS FOR MANUSCRIPT 3 
 
Figure E.1 Directed Acyclic Graph of the Association between Maternal Exposure to Ambient Cadmium Concentration and Congenital 
Diaphragmatic Hernia 
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APPENDIX F 
Table F. List of Prevalent Birth Defects Included in the Definition of 
Complex Congenital Diaphragmatic Herniaa 
Birth Defects ICD-9CM codes 
Central Nervous System  
Anencephaly 740.1 
Encephalocele 742.0 
Holoprosencephaly 742.2 
Spina bifida without anencephaly 741.0, 741.9 
Eye  
Anophthalmia/microphthalmia 743.0, 743.1 
Congenital cataract 743.3 
Cardiovascular  
Aortic valve stenosis 746.3 
Atrioventricular septal defect (endocardial 
cushion defect)  
745.61, .69 
Coarctation of aorta 747.10 
Common truncus 745.0 
Double outlet right ventricle 745.11 
Hypoplastic left heart syndrome 746.7 
Interrupted aortic arch 747.11 
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Pulmonary valve atresia and stenosis 746.01, .02 
Single Ventricle 745.3 
Tetralogy of Fallot 745.2 
Total anomalous pulmonary venous connection 747.41 
Transposition of the great arteries 745.10, .12, .19 
Tricuspid valve atresia and stenosis 746.1 
Ventricular septal defect 745.4 
Orofacial  
Cleft palate alone (without cleft lip) 749.0 
Cleft lip alone (without cleft palate) 749.1 
Cleft lip with cleft palate 749.20-749.25 
Gastrointestinal   
Biliary atresia 751.61 
Esophageal atresia/tracheoesophageal fistula 750.3 
Rectal and large intestinal atresia/stenosis 751.2 
Small intestinal atresia/stenosis 751.1 
Genitourinary  
Bladder exstrophy 753.5 
Cloacal exstrophy 751.5 
Congenital posterior valves 753.6 
Hypospadias 752.61 
Renal agenesis/hypoplasia 753.0 
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Musculoskeletal  
Clubfoot 754.51, 754.70 
Limb deficiencies (reduction defects) 755.2-755.4 
Chromosomal  
Trisomy 13 758.1 
Trisomy 21 (Down syndrome) 758.0 
Trisomy 18 758.2 
Turner syndrome 758.6 
aDefinition of Complex Congenital Diaphragmatic Hernia based on the National Birth 
Defects Prevention Network (NBDPN) list of major structural reportable defects.49 
Abbreviation: ICD-9-CM, International Classification of Diseases, 9th Revision, 
Clinical Modification 
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